Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File number: 000-41811

AMERICAN BATTERY TECHNOLOGY COMPANY

(Exact name of registrant as specified in its charter)

Nevada

33-1227980

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer

Identification No.)

100 Washington Street, Suite 100, Reno, NV 89503

(Address of principal executive offices, including zip code)

(775) 473-4744

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol(s)		Name of Each Exchange on Which Registered
Common stock, $0.001 par value		ABAT		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter quarter that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

The number of shares of common stock outstanding as of February 10, 2025 was 84,658,010.

American Battery Technology Company and Subsidiaries

Index to Form 10-Q

Part I – Financial Information (unaudited)			3

	Item 1	Unaudited Financial Statements	3

		Condensed Consolidated Balance Sheets as of December 31, 2024 and June 30, 2024	3

		Condensed Consolidated Statements of Operations for the Three and Six Months Ended December 31, 2024 and 2023	4

		Condensed Consolidated Statements of Stockholders’ Equity for Three and Six Months Ended December 31, 2024 and 2023	5

		Condensed Consolidated Statements of Cash Flows for the Six Months Ended December 31, 2024 and 2023	6

		Notes to Condensed Consolidated Financial Statements	7

	Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25

	Item 3	Quantitative and Qualitative Disclosures about Market Risk	30

	Item 4	Controls and Procedures	30

Part II. Other Information			32

	Item 1	Legal Proceedings	32

	Item 1A	Risk Factors	32

	Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	32

	Item 3	Defaults Upon Senior Securities	32

	Item 4	Mine Safety Disclosures	32

	Item 5	Other Information	33

	Item 6	Exhibits	33

Signatures			34

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

AMERICAN BATTERY TECHNOLOGY COMPANY

Unaudited Condensed Consolidated Balance Sheets

	December 31, 2024			June 30, 2024
ASSETS
Cash	$	15,623,762		$	7,001,786
Accounts receivable		323,975			228,499
Inventory (Note 4)		574,103			154,320
Grants receivable (Note 5)		27,119			191,522
Prepaid expenses and deposits		527,230			1,813,050
Subscription receivable (Note 13)		-			608,333
Restricted cash		5,000,000			-
Assets held-for-sale (Note 7)		8,408,538			8,408,538
Total current assets		30,484,727			18,406,048

Property, plant and equipment, net (Note 7)		44,534,680			46,314,966
Mining properties (Note 8)		8,392,977			8,392,977
Intangible assets (Note 9)		4,519,038			4,519,038
Right-of-use asset (Note 12)		357,431			42,103
Total assets	$	88,288,853		$	77,675,132

LIABILITIES & STOCKHOLDERS’ EQUITY
Accounts payable and accrued liabilities (Note 10)	$	7,167,414		$	9,233,806
Right-of-use lease liability – operating		108,600			117,131
Notes payable, current (Note 11)		10,165,377			6,447,361
Total current liabilities		17,441,391			15,798,298

Right-of-use lease liability – operating – long-term		250,416			-
Equity compensation liability (Note 15)		-			409,194
Total liabilities		17,691,807			16,207,492

Commitments and contingencies (Note 17)		–			–

Stockholders’ Equity:

Series A Preferred Stock Authorized: 33,334 preferred shares, par value of $0.001 per share; Issued and outstanding: nil preferred shares as of December 31, 2024 and June 30, 2024.		–			–
Series B Preferred Stock Authorized: 133,334 preferred shares, par value of $10.00 per share; Issued and outstanding: nil preferred shares as of December 31, 2024 and June 30, 2024.		-			-
Series C Preferred Stock Authorized: 66,667 preferred shares, par value of $10.00 per share; Issued and outstanding: nil preferred shares as of December 31, 2024 and June 30, 2024.		–			–
Series D Preferred Stock Authorized: 5 preferred shares, par value of $0.001 per share; Issued and outstanding: nil preferred shares as of December 31, 2024 and June 30, 2024.		-			-
Preferred stock value		–			–
Common Stock Authorized: 250,000,000 common shares, par value of $0.001 per share; Issued and outstanding: 84,392,375 and 64,061,763 common shares as of December 31, 2024, and June 30, 2024, respectively		84,390			64,059
Additional paid-in capital		310,351,869			275,589,383
Common stock issuable		(1,415,806	)		(857,470	)
Accumulated deficit		(238,423,407	)		(213,328,332	)
Total stockholders’ equity		70,597,046			61,467,640
Total liabilities and stockholders’ equity	$	88,288,853		$	77,675,132

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

AMERICAN BATTERY TECHNOLOGY COMPANY

Unaudited Condensed Consolidated Statements of Operations

	Three months ended December 31, 2024			Three months ended December 31, 2023			Six months ended December 31, 2024			Six months ended December 31, 2023
Revenue	$	332,440		$	–		$	534,400		$	–
Cost of goods sold		3,305,743			–			5,848,384			–
Gross loss		(2,973,303	)		–			(5,313,984	)		–

Expenses:
General and administrative	$	7,673,022		$	4,416,716		$	12,682,863		$	7,470,713
Research and development		2,919,865			3,569,167			4,952,000			7,183,018
Exploration costs		234,568			823,425			655,075			2,173,345
Total operating expenses		10,827,455			8,809,308			18,289,938			16,827,076

Net loss before other income (expense)		(13,800,758	)		(8,809,308	)		(23,603,922	)		(16,827,076	)

Other income (expense)
Interest income (expense)		597			(7,647	)		(3,978	)		(142,636	)
Amortization and accretion of financing costs		(732,197	)		(1,132,258	)		(1,904,546	)		(1,865,154	)
Unrealized gain (loss) on investment		-			826			-			(5,497	)
Change in fair value of derivative liability		-			(229,472	)		705,184			(229,473	)
Loss on debt extinguishment		-			-			(675,648	)		-
Loss on private placement		-			-			(567,161	)		-
Change in fair value of liability-classified financial instruments		1,116,388			-			875,100			-
Other income		15,464			-			79,896			-
Total other income (expense)		400,252			(1,368,551	)		(1,491,153	)		(2,242,760	)

Net loss	$	(13,400,506	)	$	(10,177,859	)	$	(25,095,075	)	$	(19,069,836	)

Net loss per share, basic and diluted	$	(0.18	)	$	(0.21	)	$	(0.35	)	$	(0.40	)
Weighted average shares outstanding		75,315,210			47,760,809			72,123,576			47,357,879

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

AMERICAN BATTERY TECHNOLOGY COMPANY

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

	Shares			Amount			Shares			Amount			Capital			Issuable			Deficit			Total
	Preferred Stock						Common Stock						Additional Paid-In			Common Stock			Accumulated
	Shares			Amount			Shares			Amount			Capital			Issuable			Deficit			Total
Balance, June 30, 2024		-			-			64,061,763		$	64,059		$	275,589,383			(857,470	)	$	(213,328,332	)	$	61,467,640
Shares issued upon vesting of share-based awards		-			-			353,221			353			(353	)		-			-			-
Stock-based compensation expense		-			-			-			-			2,420,747			-			-			2,420,747
Shares issued pursuant to an At-The-Market offering		-			-			5,938,786			5,939			6,218,486			102,743			-			6,327,168
Settlement of receivable pursuant to share purchase agreement		-			-			487,838			488			607,848			(608,336	)		-			-
Reclassification of equity-linked contracts to liabilities		-			-			-			-			(502,627	)		-			-			(502,627	)
Issuance of Series D Redeemable Preferred shares		5			100			-			-			-			-			-			100
Issuance of common shares and warrants pursuant to subscription agreements		-			-			1,774,213			1,774			533,623			-			-			535,397
Shares issued pursuant to debt extinguishment		-			-			726,216			726			740,014			-			-			740,740
Settlement of receivable pursuant to share purchase agreement (Tysadco)		-			-			-			-			-			50,000			-			50,000

Net loss for the period		-			-			-			-			-			-			(11,694,569	)		(11,694,569	)
Balance, September 30, 2024		5		$	100			73,342,037		$	73,339		$	285,607,121		$	(1,313,063	)	$	(225,022,901	)	$	59,344,596
Repurchase of Series D Redeemable Preferred shares		(5	)		(100	)		-			-			-			-			-			(100	)
Shares issued upon vesting of share-based awards		-			-			1,073,399			1,074			(1,074	)		-			-			-
Issuance of common shares under the Employee Stock Purchase Plan		-			-			177,440			178			140,568			-			-			140,746
Reclassification of equity-classified awards from equity compensation liability		-			-			-			-			467,191			-			-			467,191
Stock-based compensation expense		-			-			-			-			6,330,914			-			-			6,330,914
Shares issued pursuant an At-The-Market offering		-			-			690,553			690			695,774			(102,743	)		-			593,721
Reclassification of derivative equity instruments from long-term liabilities		-			-			-			-			2,066,569			-			-			2,066,569
Rescission of common shares and warrants pursuant to subscription agreements		-			-			(875,000	)		(875	)		-			-			-			(875	)
Shares issued pursuant to troubled debt restructuring		-			-			1,210,360			1,210			1,142,580			-			-			1,143,790
Issuance of common shares and warrants pursuant to registered direct offerings		-			-			8,773,586			8,774			13,902,226			-			-			13,911,000
Net loss for the period		-			-			-			-			-			-			(13,400,506	)		(13,400,506	)
Balance, December 31, 2024		-		$	-			84,392,375		$	84,390		$	310,351,869		$	(1,415,806	)	$	(238,423,407	)	$	70,597,046

AMERICAN BATTERY TECHNOLOGY COMPANY

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

	Shares		Amount		Shares			Amount			Capital			Issuable			Deficit			Total
	Preferred Stock				Common Stock						Additional Paid-In			Common Stock			Accumulated
	Shares		Amount		Shares			Amount			Capital			Issuable			Deficit			Total
Balance, June 30, 2023		-		-		45,888,131		$	45,887		$	223,134,798			(1,484,693	)	$	(160,826,508	)	$	60,869,484
Shares issued for professional services		-		-		1,326			1			15,174			(15,307	)		-			(132	)
Shares issued upon vesting of share-based awards		-		-		132,142			135			(135	)		-			-			-
Stock-based compensation expense		-		-		-			-			3,369,269			-			-			3,369,269
Shares issued pursuant to rounding of reverse stock split		-		-		59,164			59			(59	)		-			-			-
Shares reclaimed pursuant to asset acquisition		-		-		(128,206	)		(128	)		(1,255,650	)		1,500,000			-			244,222
Shares issued pursuant to share purchase agreement, net of issuance costs		-		-		306,252			306			3,009,694			-			-			3,010,000
Shares issued pursuant to warrant exercises		-		-		45,545			46			(46	)		37,500			-			37,500
Net loss for the period		-		-		-			-			-			-			(8,891,978	)		(8,891,978	)
Balance, September 30, 2023		-	$	-		46,304,354		$	46,306		$	228,273,045		$	37,500		$	(169,718,486	)	$	58,638,365
Balance		-	$	-		46,304,354		$	46,306		$	228,273,045		$	37,500		$	(169,718,486	)	$	58,638,365
Shares issued upon vesting of share-based awards		-		-		180,811			181			(181	)		-			-			-
Stock-based compensation expense		-		-		-			-			4,261,327			-			-			4,261,327
Shares issued pursuant to share purchase agreement, net of issuance costs		-		-		2,799,973			2,800			12,829,925			-			-			12,832,725
Shares issued pursuant to warrant exercises		-		-		58,087			58			37,440			(37,500	)		-			(2	)
Net loss for the period		-		-		-			-			-			-			(10,177,859	)		(10,177,859	)
Balance, December 31, 2023		-	$	-		49,343,225		$	49,345		$	245,401,556		$	-		$	(179,896,345	)	$	65,554,556
Balance		-	$	-		49,343,225		$	49,345		$	245,401,556		$	-		$	(179,896,345	)	$	65,554,556

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

AMERICAN BATTERY TECHNOLOGY COMPANY

Unaudited Condensed Consolidated Statements of Cash Flows

	Six months ended December 31, 2024			Six months ended December 31, 2023

Cash Flows From Operating Activities:
Net loss	$	(25,095,075	)	$	(19,069,836	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense		2,518,001			81,410
Accretion of financing costs		1,904,546			1,865,154
Amortization of right-of-use asset		52,315			50,525
Write-down of inventory to net realizable value		2,394,274			-
Unrealized loss on investment		-			5,497
Stock-based compensation		9,502,030			7,691,511
Shares issued for professional services		-			(448	)
Change in fair value of derivative liability		(705,184	)		229,473
Change in fair value of conversion option		(138,060	)		-
Change in fair value of liability-classified equity-linked contracts		(737,040	)		-
Loss on extinguishment of debt		675,648			-
Loss on private placement		567,161			-
Changes in operating assets and liabilities:
Accounts receivable		(95,476	)		-
Inventory		(2,814,057	)		(489,238	)
Grants receivable		164,403			(326,170	)
Prepaid expenses and deposits		1,285,820			416,234
Other current assets		-			(316,351	)
Accounts payable and accrued liabilities		(2,053,400	)		2,502,865
Right-of-use lease liabilities		(241,884	)		(59,326	)
Net Cash Used in Operating Activities		(12,815,978	)		(7,418,700	)
Cash Flows From Investing Activities:
Other acquisition deposits		-			(279,878	)
Acquisition of property, plant and equipment, and water rights		(1,509,581	)		(10,418,868	)
Purchase of water rights/intangible assets		-			(169,714	)
Net Cash Used in Investing Activities		(1,509,581	)		(10,868,460	)
Cash Flows From Financing Activities:
Proceeds from exercise of share purchase warrants		-			37,499
Proceeds from employee stock purchase plan		140,746			-
Proceeds from issuance of common shares through At-The-Market offering		7,579,122			-
Proceeds from subscription agreements (Note 13)		1,900,000			-
Proceeds from registered direct offerings		15,000,000			-
Payment of issuance costs, registered direct offerings		(1,089,000	)		-
Proceeds from notes payable, net of issuance costs		9,900,000			20,287,118
Principal paid on notes payable		(5,483,333	)		(11,400,000	)
Proceeds from share purchase agreement, net of issuance costs		-			14,689,178
Net Cash Provided by Financing Activities		27,947,535			23,613,795

Increase in Cash and Restricted Cash		13,621,976			5,326,635
Cash and Restricted Cash – Beginning of Period		7,001,786			2,320,149
Cash and Restricted Cash – End of Period	$	20,623,762		$	7,646,784

Supplemental disclosures (Note 16)

The accompanying notes are an integral part of these condensed consolidated unaudited financial statements.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

1. Organization and Nature of Operations

American Battery Technology Company (“the Company” or “ABTC”) is an integrated critical battery materials company in the lithium-ion battery industry that is working to increase the domestic U.S. production of battery materials, such as lithium, nickel, cobalt, and manganese through its engagement in the exploration of new primary resources of battery metals, in the development and commercialization of new technologies for the extraction of these battery metals from primary resources, and in the commercialization of an internally developed integrated process for the recycling of lithium-ion batteries. Through this three-pronged approach the Company is working to both increase the domestic production of these battery materials, and to ensure that as these materials reach their end of lives that the constituent elemental battery metals are returned to the domestic manufacturing supply chain in a closed-loop fashion.

The Company was incorporated under the laws of the State of Nevada on October 6, 2011, for the purpose of acquiring rights to mineral properties with the eventual objective of being a producing mineral company. We have a limited operating history and generated our initial revenue in the fourth quarter of fiscal 2024. Our principal executive offices are located at 100 Washington Ave., Suite 100, Reno, Nevada 89503.

2. Liquidity and Going Concern

During the six months ended December 31, 2024, the Company incurred a net loss of $25.1 million and used cash of $12.8 million for operating activities. At December 31, 2024, the Company has a cash balance of $20.6 million (of which $15.6 million was available and $5.0 million is restricted) and an accumulated deficit of $238.4 million.

The continuation of the Company as a going concern is dependent upon generating profit from its operations and its ability to obtain debt or equity financing. There is no assurance that the Company will be able to generate sufficient profits, obtain such financings, or obtain them on favorable terms, which could limit its operations. Any such financing activities are subject to market conditions. These uncertainties cause substantial doubt to exist as to the Company’s ability to continue as a going concern for 12 months from issuance of these financial statements. These condensed consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. These adjustments could be material.

Based on its current operating plan, unless the Company generate income from the operations of its facilities or raises additional capital (debt or equity), it is possible that the Company will be unable to maintain its financial covenants under our existing Note agreement (Note 11). If such covenant violations are not waived by the Note holder, it would result in an event of default, causing an acceleration of the outstanding balances. If the Company does raise additional capital through public or private equity offerings, as opposed to debt or additional Note issuances, the ownership interests of its existing stockholders may be diluted.

3. Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the U. S. Securities and Exchange Commission (“SEC”) and on the same basis as the Company prepares its annual audited consolidated financial statements.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

The condensed consolidated balance sheet at December 31, 2024, and the condensed consolidated statements of operations, comprehensive income (loss), and stockholders’ equity, and cash flows for the three and six months ended December 31, 2024 and 2023 are unaudited, but include all adjustments, consisting of normal recurring adjustments the Company considers necessary for a fair presentation of the financial position, operating results, and cash flows for the periods presented. The results for the six months ended December 31, 2024 are not necessarily indicative of results to be expected for the year ending June 30, 2025 or for any future interim period. The condensed consolidated balance sheet at June 30, 2024 has been derived from audited financial statements; however, it does not include all of the information and notes required by U.S. GAAP for complete financial statements. The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements for the year ended June 30, 2024 and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2024 as filed with the SEC on September 23, 2024 (the “Fiscal 2024 Form 10-K”). The Company’s consolidated subsidiaries consist of its wholly owned subsidiaries, LithiumOre Corporation (formerly Lithortech Resources Inc), and ABTC 2500 Peru LLC (formerly Aqua Metals Transfer LLC).

The accompanying condensed consolidated interim financial statements include the accounts of the Company and its subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.

The Company has made a presentation change to reclassify short-term right-of-use operating lease liabilities out of accounts payable and accrued liabilities in the balance sheet. The change to reclassify the amount in the prior period has been made to conform to the current period presentation.

As disclosed in the Company’s Fiscal 2024 Form 10-K, subsequent to the issuance of the Company’s Fiscal 2023 consolidated financial statements, the Company identified errors in the application of Accounting Standards Codification (“ASC”) 710, “Compensation-General,” and ASC 718, “Compensation-Stock Compensation,” related to expense recognition for cash and equity awards that are subject to both service and performance conditions. ASC 710 and ASC 718 require recognition of compensation cost once achievement of the performance condition becomes probable as the requisite service is provided. Historically, the Company did not recognize compensation cost for certain cash and equity awards until the performance conditions in the form of milestones were achieved, and for the Company’s common share warrant performance-based awards, no compensation cost had previously been recognized when the performance conditions either became probable of achievement or were achieved. As the common share warrant and restricted stock unit (“RSU”) performance-based awards to executive officers and key employees are granted with a fixed dollar value and settled in a variable number of common share warrants or RSUs, these awards are liability-classified until the number of common share warrants or RSUs are fixed, and the corresponding compensation cost should be recorded to current or long-term liabilities, or additional paid-in capital, depending on expected timing of settlement of the award, once the performance conditions become probable of achievement.

The correction of this error resulted in an increase in compensation cost of $0.6 million and $2.2 million for the three and six months ended December 31, 2023, respectively. As certain of these awards are liability-classified, the correction of this error resulted in an increase of $0.3 million in accounts payable and accrued liabilities and less than $0.1 million in the equity compensation liability, and an increase of $1.8 million in additional paid-in capital for the awards where the number of common share warrants or RSUs are fixed as of December 31, 2023.

The Company also identified an error in application of ASC 815, “Derivatives and Hedging,” related to the initial and subsequent recognition of a freestanding call option in the Company’s convertible notes that does not qualify for equity classification. ASC 815 requires bifurcation of the conversion option with subsequent changes in the fair value of the bifurcated derivative to be recorded in earnings. At issuance of the convertible notes, the Company should have recognized a derivative liability and a corresponding discount on the convertible notes resulting from bifurcation of the derivative, with subsequent changes in the fair value of the derivative liability and accretion of the discount recorded in earnings.

The correction of this error resulted in an increase in interest and other expense of $0.3 million for the quarter ended December 31, 2023. For the six-month period ended December 31, 2023, the error resulted in an increase in interest and other expenses of $0.4 million.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

	As Reported			Adjustments			As Corrected
	Three months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Operating expenses
General and administrative	$	4,310,452		$	106,264		$	4,416,716
Research and development		3,148,873			420,294			3,569,167
Exploration		771,523			51,902			823,425
Total operating expenses		8,230,848			578,460			8,809,308

Net loss before other income (expense)	$	(8,230,848	)	$	(578,460	)	$	(8,809,308	)

Other income (expense)
Amortization and accretion of financing costs	$	(1,053,766	)	$	(78,492	)	$	(1,132,258	)
Change in fair value of derivative liability		-			(229,472	)		(229,472	)
Total other income (expense)		(1,060,587	)		(307,965	)		(1,368,551	)

Net loss attributable to common stockholders	$	(9,291,435	)	$	(886,424	)	$	(10,177,859	)
Net loss per share, basic and diluted	$	(0.19	)	$	(0.02	)	$	(0.21	)

	As Reported			Adjustments			As Corrected
	Six months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Operating expenses
General and administrative	$	7,259,298		$	211,415		$	7,470,713
Research and development		5,304,187			1,878,831			7,183,018
Exploration		2,051,305			122,040			2,173,345
Total operating expenses		14,614,790			2,212,286			16,827,076

Net loss before other income (expense)	$	(14,614,790	)	$	(2,212,286	)	$	(16,827,076	)

Other income (expense)
Amortization and accretion of financing costs	$	(1,760,497	)	$	(104,657	)	$	(1,865,154	)
Change in fair value of derivative liability		-			(229,473	)		(229,473	)
Total other income (expense)		(1,908,630	)		(334,130	)		(2,242,760	)

Net loss attributable to common stockholders	$	(16,523,420	)	$	(2,546,416	)	$	(19,069,836	)
Net loss per share, basic and diluted	$	(0.35	)	$	(0.05	)	$	(0.40	)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

	As Reported			Adjustments			As Corrected
	Three months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Stockholders’ Equity

Additional paid-in capital:
Stock-based compensation expense		3,836,466			424,861			4,261,327
Balance, December 31, 2023	$	243,020,935		$	2,380,621		$	245,401,556

Accumulated deficit
Net loss for period		(9,291,435	)		(886,424	)		(10,177,859	)
Balance, December 31, 2023	$	(176,496,995	)	$	(3,399,350	)	$	(179,896,345	)

Total stockholders’ equity
Balance, December 31, 2023	$	66,573,285		$	(1,018,729	)	$	65,554,556

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

	As Reported			Adjustments			As Corrected
	Six months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Stockholders’ Equity

Additional paid-in capital:
Stock-based compensation expense		5,757,908			1,872,688			7,630,596
Balance, December 31, 2023	$	243,020,935		$	2,380,621		$	245,401,556

Accumulated deficit
Net loss for period		(16,523,420	)		(2,546,416	)		(19,069,836	)
Balance, December 31, 2023	$	(176,496,995	)	$	(3,399,350	)	$	(179,896,345	)

Total stockholders’ equity
Balance, December 31, 2023	$	66,573,285		$	(1,018,729	)	$	65,554,556

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

	As Reported			Adjustments			As Corrected
	Six months ended December 31, 2023
	As Reported			Adjustments			As Corrected
Operating Activities
Net loss attributable to stockholders	$	(16,523,420	)	$	(2,546,416	)	$	(19,069,836	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and accretion expense	$	1,760,497		$	104,657		$	1,865,154
Stock-based compensation		5,757,908			1,933,603			7,691,511
Shares issued for professional services		(132	)		(316	)		(448	)
Change in fair value of derivative liability		-			229,473			229,473
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	$	2,164,539		$	279,000		$	2,443,539

Net cash used in operating activities	$	(7,418,700	)	$	-		$	(7,418,700	)

Use of Estimates

The preparation of these condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates estimates and assumptions related to the fair value of stock-based compensation, valuation and recoverability of long-lived assets and intangible assets subject to impairment testing, and deferred income tax asset valuation allowances.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2024 and June 30, 2024.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Fair Value of Financial Instruments

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is an exit price concept that assumes an orderly transaction between willing market participants and is required to be based on assumptions that market participants would use in pricing an asset or a liability. Current accounting guidance establishes a three-tier fair value hierarchy as a basis for considering such assumptions and for classifying the inputs used in the valuation methodologies. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are as follows:

Level 1: Quoted prices (unadjusted) in active markets for identical assets and liabilities that the reporting entity can assess at the measurement date.

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3: Unobservable inputs for the asset or liability which include the Company’s assumptions regarding the data market participants would use in pricing the asset or liability based on the best information available under the circumstances.

The carrying values of the Company’s cash, accounts receivable, prepaid expenses and deposits, notes payable, accounts payable and accrued liabilities approximate fair value due to their short maturities.

The Company’s recurring fair value measurements include the valuation of the derivative liabilities for the bifurcated notes payable freestanding call and conversion options and for the liability-classified equity-linked contracts, both of which are classified as Level 3 of the fair value hierarchy. See Notes 6 and 11 for relevant fair value disclosures. Given use of unobservable inputs, there is inherently uncertainty that the inputs could reasonably have been different as of the reporting date.

The Company’s non-recurring fair value measurements include the valuation of the assets held-for-sale as of December 31, 2024. See Note 7 for relevant fair value disclosures.

Adoption of Recent Accounting Pronouncements

The Company continually assesses new accounting pronouncements to determine their applicability. When it is determined a new accounting pronouncement affects the Company’s financial reporting, the Company undertakes a review to determine the consequences of the change to its consolidated financial statements and assures there are sufficient controls in place to ascertain the Company’s consolidated financial statements properly reflect the change.

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting - Improvements to Reportable Segment Disclosures”, which updates reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance. The amendments in this ASU are effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of determining the effect this ASU will have on the disclosures contained in the notes to the consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, “Improvements to Income Tax Disclosures”, which updates income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This ASU also includes certain other amendments to improve the effectiveness of income tax disclosures. The amendments in this ASU are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company is in the process of determining the effect this ASU will have on the disclosures contained in the notes to the consolidated financial statements.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

In November 2024, the FASB Issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” The amendments in this update require disclosures, in the notes to financial statements, of specified information about certain costs and expenses. The amendment clarifies which certain costs and expenses that are included in cost of sales and selling, general, and administrative expense categories that should be disclosed with qualitative descriptions of amounts that are not separately disaggregated quantitatively. Additionally, the amendment requires disclosure of total amounts of selling expenses and an entity’s definition of selling expense. The update will be effective for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is in the process of determining the effect this ASU will have on the disclosures contained in the notes to the consolidated financial statements.

4. Inventories

The Company’s inventory for its lithium-ion battery recycling operation is comprised of raw materials, in the form of battery feedstock, and finished goods, in the form of black mass and other metals. Inventory is valued at the lower of average cost or net realizable value. The carrying value of inventory includes those costs to acquire battery feedstock and any related carrying and processing costs incurred by the Company.

Schedule of Inventories

	December 31, 2024		June 30, 2024
Raw materials	$	449,665	$	66,088
Finished goods		124,438		88,232
Total	$	574,103	$	154,320

5. Government Grants and Tax Credit Awards

Grants receivable represent qualifying costs incurred where there is reasonable assurance that the conditions of the grant have been met but the corresponding funds have not been received as of the reporting date. As collections from the federal government have been and are expected to continue to be timely, no allowance for doubtful accounts has been established. If amounts become uncollectible, they will be charged to operations. Grants receivable was $27,000 and $0.2 million as of December 31, 2024 and June 30, 2024, respectively. The Company recognizes invoiced government funds as an offset to R&D costs in the period the qualifying costs are incurred. During the six months ended December 31, 2024, the Company recognized $2.3 million of invoiced government funds as an offset to R&D costs. Grants related to investments in property and equipment are recognized as a reduction to the cost basis of the underlying assets with an ongoing reduction to depreciation expense over the assets’ estimated useful life.

On January 20, 2021, the U.S. Department of Energy (“DOE”) announced that the Company had been selected for award negotiation for a three-year project with a total budget of $4.5 million for the field demonstration of its selective leaching, targeted purification, and electro-chemical production of battery grade lithium hydroxide from domestic claystone resources technology. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, or up to $2.3 million. The prime agreement contract for this grant (the “AMMTO grant”) was issued with a project start date of October 1, 2021. The Company began receiving funds related to this award during the fiscal year ending June 30, 2022. As of December 31, 2024, the cumulative funds invoiced for this grant totaled $2.0 million, which represents 90% of the total eligible reimbursements.

On August 16, 2021, the Company received a contract award for a 30-month project with a total budget of $2.0 million from the United States Advanced Battery Consortium (the “USABC grant”) as part of a competitively bid project, through which the Company will receive reimbursement for up to $0.5 million of eligible expenditures. The objective of the contract award is for the commercial-scale development and demonstration of an integrated lithium-ion battery recycling system, the production of battery cathode grade metal products, the synthesis of high energy density active cathode material from these recycled battery metals, and the fabrication of large format automotive battery cells from these recycled materials and the testing of these cells against otherwise identical cells made from virgin sourced metals. The Company began receiving funds related to this award during the fiscal year ended June 30, 2024. As of December 31, 2024, the cumulative funds invoiced for this grant totaled $0.5 million, which represents 100% of the total eligible reimbursements.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

On October 21, 2022, the U.S. DOE announced that the Company had been selected for award negotiation for a five-year project with a total budget of $115.5 million to design, construct, and commission a first-of-kind lithium hydroxide refinery using Nevada-based claystone as the feedstock to expand domestic manufacturing of battery grade lithium hydroxide for lithium-ion batteries for electric vehicles, with a focus on domestic processing of materials and components that are currently imported from foreign countries. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, up to $57.7 million. The prime agreement contract for this grant was issued with a project start date of September 1, 2023. The Company began receiving funds related to this award during the period ending December 31, 2023. As of December 31, 2024, the cumulative funds invoiced for this grant totaled $3.2 million, which represents 6% of the total eligible reimbursements.

On November 17, 2022, the U.S. DOE announced that the Company had been selected for award negotiation for a three-year project with a total budget of $20.0 million to demonstrate and commercialize next generation techniques for its lithium-ion battery recycling processes to produce low-cost and low-environmental impact domestic battery materials. Through this grant award the Company is eligible to receive reimbursement of up to 50% of eligible expenditures, up to $10.0 million. The prime agreement contract for this grant was issued with a project start date of October 1, 2023. The Company began receiving funds related to this award during the period ending December 31, 2023. As of December 31, 2024, the cumulative funds invoiced for this grant totaled $1.1 million, which represents 11% of the total eligible reimbursements.

On March 28, 2024, ABTC was selected for a tax credit for up to $19.5 million through the Qualifying Advanced Energy Project Credits program (48C). This tax credit was granted by the U.S. Department of Treasury Internal Revenue Service following a highly competitive technical and economic review process performed by the U.S.DOE, which evaluated the feasibility of applicant facilities to advance America’s buildout of globally competitive critical material recycling, processing, and refining infrastructure. This tax credit may be utilized both for the reimbursement of capital expenditures spent to date and also future capital expenditures at ABTC’s battery recycling facility in the Tahoe-Reno Industrial Center (TRIC) in Storey County, Nevada. As of December 31, 2024, the Company has incurred qualifying expenditures for this tax credit but will not recognize any amounts until it has reasonable assurance of compliance with the relevant standards.

Also on March 28, 2024, ABTC was selected for an additional tax credit of up to $40.5 million through the 48C program, which may be used in support of the design and construction of a new commercial battery recycling facility to be located in the United States. As of December 31, 2024, the Company has not incurred any qualifying expenditures towards this tax credit.

On September 23, 2024, the U.S. DOE announced that the Company had been selected for award negotiations for a highly competitive grant for $150 million to be applied towards the construction of a new lithium-ion battery recycling facility. On December 18, 2024, the Company received a contracted grant award for $144 million of federal investment by the DOE, with these funds awarded to the Company and its subcontractor Argonne National Laboratory, to support the construction of a new lithium-ion battery recycling facility.

6. Derivative Liabilities

During the quarter ended December 31, 2024, the Company’s embedded conversion feature on its convertible notes and its outstanding warrants had been treated as derivative liabilities for accounting purposes under ASC 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Equity,” due to insufficient authorized shares to settle these outstanding equity-linked contracts, while the terms of these instruments still allowed the holders to exercise which would require the Company to net-cash settle the instrument. In such cases, the Company adopted a sequencing approach under ASC 815-40 to determine the classification of its equity-linked financial instruments at issuance and at each subsequent reporting date. Under this sequencing policy, the Company reclassified to liabilities those equity-linked financial instruments with the most recent issuance or modification date. The derivative liabilities were initially recorded at fair value and subsequently re-valued each reporting date, with changes in fair value reported in the condensed consolidated statements of operations. The Company utilized the Black-Scholes option-pricing model to value the derivative liabilities at initial reclassification and subsequent valuation dates, adjusted for instrument-specific terms as applicable.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

In August 2024, the Company issued common shares and warrants to purchase common shares under private placement subscription agreements. See further discussion at Note 13. As there were insufficient authorized shares available at the time of issuance, the warrants were classified as derivative liabilities, measured at fair value as of issuance, and re-measured to fair value as of September 30, 2024. Of the $1.9 million in proceeds received from the private placement, $0.6 million was received from related parties of the Company, including current employees and an immediate family member of the Chief Executive Officer. The Company recognized common shares and warrants to purchase common shares with a total fair value of $1.4 million, compensation expense of $0.7 million and a loss on private placement of $0.1 million in the condensed consolidated statements of operations. The Company recognized less than a $0.1 million loss on change in fair value of these liability-classified equity-linked financial instruments.

For the remaining private placement subscription agreements, the Company recognized the fair value of the warrants of $1.7 million and a loss on private placement of $0.6 million as of issuance, and a fair value of $1.7 million as of September 30, 2024, with the loss on change in fair value of less than $0.1 million recorded to change in fair value of liability-classified equity-linked contracts in the condensed consolidated statements of operations. The associated derivative liability was included in long-term liabilities in the condensed consolidated balance sheets. In November 2024, a portion of the private placement subscription agreements were rescinded. Prior to rescission, a gain of $0.3 million was recognized upon revaluation of the warrant liability, reducing the warrant liability from $1.2 million to $0.9 million. A gain of less than $0.1 million was recognized upon extinguishment of the warrant liability at the rescission date. A payable of $0.9 million is included in accounts payable and accrued liabilities on the condensed consolidated balance sheet as of December 31, 2024 for the return of the subscription agreement proceeds to the investors.

In September 2024, the Company’s convertible notes were amended to increase the conversion rate of the conversion option. See further discussion at Note 11. Upon modification, the Company no longer had sufficient authorized shares to settle all equity-linked contracts including the convertible notes upon a potential conversion and accordingly, the embedded conversion feature was bifurcated from the convertible notes to be accounted for as a derivative liability. The Company calculated a fair value of the bifurcated conversion feature of $0.7 million as of the modification date and a fair value of $0.9 million as of September 30, 2024, with the loss on change in fair value of $0.2 million recorded to change in fair value of liability-classified financial instruments in the condensed consolidated statements of operations. The associated derivative liability is included in long-term liabilities in the condensed consolidated balance sheets.

In November 2024, the Company’s shareholders approved and adopted an amendment to the articles of incorporation to increase the number of authorized shares of the Company’s common stock from 80,000,000 to 250,000,000. Upon the increase, the Company had sufficient authorized shares available to settle all equity-linked contracts including the convertible notes and warrants to purchase common shares included in derivative liabilities. As a result, the Company revalued the bifurcated conversion feature and the warrants to purchase common shares as of the shareholder approval date and reclassified the associated derivative liabilities from long-term liabilities to additional paid-in capital in the condensed consolidated balance sheets. The Company recognized a $0.8 million gain on change in fair value of the derivative liabilities prior to the reclassification to equity from long-term liabilities. The amount reclassed to equity totaled $2.1 million.

The table below sets forth the Black-Scholes inputs and assumptions for the Company’s valuation and re-valuation of its derivative liabilities for the three months ending December 31:

	2024
Weighted average expected term (years)		0.01 – 4.67
Risk-free interest rate		4.26% - 4.69	%
Dividend yield		0	%
Volatility		6.69% - 117.89	%

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

A summary of the activity related to derivative liabilities for the three months ending December 31, 2024, is as follows:

Schedule of Derivative Liabilities

	Warrant Derivative Liabilities			Conversion Option Derivative Liability			Total Derivative Liabilities

Balance, September 30, 2024	$	3,117,647		$	939,435		$	4,057,082
Change in fair value		(639,727	)		(388,365	)		(1,028,092	)
Fair value of extinguishments during the period		(87,421	)		-			(87,421	)
Fair value of reclassifications to accounts payable during the period		(875,000	)		-			(875,000	)
Fair value of reclassifications to equity during the period		(1,515,499	)		(551,070	)		(2,066,569	)
Balance, December 31, 2024	$	-		$	-		$	-

7. Property, Plant and Equipment

The table below presents the property, plant and equipment as of December 31, 2024 and June 30, 2024:

Schedule of Property and Equipment

	December 31, 2024			June 30, 2024
Land	$	8,860,916		$	8,860,916
Building		16,633,661			24,867,784
Equipment and vehicles		23,232,967			14,313,970
Total property, plant and equipment		48,727,544			48,042,670
Less: accumulated depreciation		(4,192,864	)		(1,727,704	)
Property, plant and equipment, net		44,534,680		$	46,314,966

The Company recognized depreciation expense of $1.2 million and $44,908 for the three months ended December 31, 2024 and 2023, respectively. The Company recognized depreciation expense of $2.5 million and $81,410 for the six months ended December 31, 2024 and 2023, respectively.

During the fourth quarter of fiscal 2024, the Company approved a plan to sell certain assets comprised primarily of land and a building from its Fernley location. The Company made this decision due to the acquisition of the Peru facility that would accelerate its time to production and commercialization. The assets located at Fernley had a carrying amount of $18.6 million and water rights with a carrying amount of $0.1 million. These assets have been classified as held-for-sale as of June 30, 2024 and are expected to be sold by September 2025. The Company recorded an impairment charge on the assets held-for-sale of $10.3 million for the fiscal year ended June 30, 2024. The fair value of the assets held-for-sale is classified within Level 3 of the fair value hierarchy and was determined based on indicative market listing prices of the assets. As of December 31, 2024, there were no changes to the valuation of assets held-for-sale.

8. Mining Properties

On July 21, 2022, the Company exercised the option to purchase the rights to unpatented lode claims in Tonopah, Nevada. Since that time, the Company has worked with third parties to conduct drill programs and analysis to verify the grade and continuity of the mining claims. Over 50% of the inferred mineral resources have been upgraded to measured and indicated classifications. The Company is still in the exploration stage and expenses all mineral exploration costs. If the Company identifies proven and probable reserves and develops an economic plan for operating a mine, it will enter the development stage and capitalize future costs until production is established.

On July 22, 2023, the Company began a third exploration program to advance its Tonopah Flats Lithium Project. This drill program includes core infill and step out drilling to support the evolution of its domestic resource with the goal of upgrading to a ‘measured and indicated’ resource classification. The Company selected and engaged KB Drilling for the collection of infill and step out samples for this latest drill program, which consists of sample collections from eight additional drill holes and includes 6,500 feet of total drilling.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

In December 2023, the Company entered into a vacant land offer and acceptance agreement for the Company’s acquisition of certain mineral patents totaling $0.2 million which, was capitalized to mining properties.

On April 24, 2024, the Company announced the completion of the “Amended Resource Estimate and Initial Assessment with Project Economics for the Tonopah Flats Lithium Project, Esmeralda and Nye Counties, Nevada, USA” (“Amended IA”) and the publication of the S-K 1300 Technical Report Summary (“TRS”) disclosing mineral resources, including an initial economic assessment, for the Tonopah Flats Lithium Project. The TRS was completed by RESPEC Company LLC, a qualified person, in compliance with Item 1300 of Regulation S-K and with an effective date of April 5, 2024.

On January 21, 2025, the Company commenced a new drill program which is the next step in accelerating the commercialization of the lithium resource is the completion and publication of a prefeasibility study (PFS). A critical operation of the PFS is performing this drill program to provide the geotechnical data to define the structural mine pit shape, to increase the resolution of the 3D resource model, and to add to the understanding of the high-grade continuity within the proposed pit. This drill program also includes core sample collections which will be assayed and characterized to further define the resource to the previously unexplored southwest section of the claim block and to work to increase the size of the overall lithium resource.

9. Intangible Assets

On September 12, 2023, the Company acquired approximately 40.52-acre feet of water rights from the Thomas C. Woodward Living Trust, valued at $0.1 million. The water rights are treated in accordance with ASC 350, “Intangible Assets,” and have an unlimited useful life subject to beneficial use.

The Company’s acquisition of the commercial-scale battery recycling facility at the TRIC included water rights valued at $0.7 million and are described as an eighteen and forty-five one-hundredths (18.45) acre-foot/annually portion of the Truckee-Carson Irrigation District. These have an unlimited useful life upon assignment to a property through use of a will-serve, which has no expiration date.

The table below presents total intangible assets at:

Schedule of Intangible Assets

		December 31, 2024				June 30, 2024
Water rights		$	4,519,038			$	4,519,038

10. Accounts Payable and Accrued Liabilities

The table below presents total accounts payable and accrued liabilities at:

	December 31, 2024		June 30, 2024
Trade payables	$	2,038,587	$	4,255,398
Accrued fixed assets		225,104		996,970
Accrued expenses		4,903,723		2,244,265
Market agreement settlement		-		1,800,000
Total accounts payable and accrued liabilities	$	7,167,414	$	9,296,633

On July 3, 2024, the Company and Mercuria Energy America, LLC agreed to resolve their respective disputes related to a Marketing Agreement entered into in May 2023. Under the terms of the Settlement Agreement, the Company agreed to make six monthly payments to Mercuria Energy America, LLC of $0.3 million each. Upon the completion of the payments, the parties agreed to release any and all claims, disputes, actions, suits, proceedings, demands and/or liabilities in law and/or equity or otherwise. The total amount of payments due of $1.8 million was accrued as of June 30, 2024. As of December 31, 2024, all amounts have been paid.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

11. Notes Payable

On August 29, 2023, the Company and High Trail (the “Buyers”) entered into a Securities Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company can sell to the Buyers up to $51.0 million of a new series of senior secured convertible notes (the “Notes”), of which $25.0 million was initially received. The Company analyzed the conversion features of the Notes for derivative accounting considerations under ASC 815-15, “Derivatives and Hedging,” and determined a freestanding call option should be bifurcated and separately accounted for as a derivative liability. Accordingly, the derivative liability is carried at fair value at each reporting date with the corresponding gain or loss reflected in earnings in the condensed consolidated statements of operations. See Correction of Previously Issued Consolidated Financial Statements in Note 3. The Company determined the derivative liability to have a fair value of $0.4 million at issuance of the Notes. For the three months ended September 30, 2024, the Company recorded a gain of $0.7 million within the change in fair value of the derivative liability in the condensed consolidated statements of operations. As of September 30, 2024, the fair value of the derivative liability was determined to be nil given the expiration of the freestanding call option on October 1, 2024.

The carrying value, net of debt discount and issuance costs, was being accreted over the term of the Notes from date of issuance to date of full repayment, expected to be in October 2024 based on partial redemption payments, using the effective interest rate method.

On September 13, 2024, the Notes were amended to allow payment of principal totaling $0.6 million in common shares of the Company in lieu of cash, with the remaining principal due in September 2024 deferred to October 2024. Subsequent to September 30, 2024, further payment on the Notes had been deferred by the Buyers while negotiations on a potential amendment to the Notes are on-going. Total common shares of 726,216 were issued with a fair market value of $0.7 million. The Notes were also amended to increase the conversion option rate. The Company concluded that the amendment to the Notes was an extinguishment for accounting purposes due to the increase in the conversion option fair value. The Company recognized a $0.7 million loss on extinguishment in the condensed consolidated statement of operations, comprised of the write-off of the remaining debt discount and debt issuance costs of $0.6 million and the excess of fair value of the common shares paid in lieu of cash over the principal owed of $0.1 million.

On November 14, 2024, the Purchase Agreement and Notes were amended to provide for the issuance of a new series of senior secured convertible notes (the “2024 Notes”) in the aggregate principal amount of $12.0 million, less discount totaling $2.1 million. The amendment also allowed payment of principal of the Notes totaling $1.1 million in common shares of the Company in lieu of cash, with the remaining principal of the Notes of $1.8 million paid with proceeds from issuance of the 2024 Notes. The 2024 Notes bear zero coupon, mature on September 1, 2025, and require $5.0 million in cash to be maintained in a restricted account. The Buyers may request partial redemptions of up to an aggregate of $1.0 million on the 1st of each month beginning on January 1, 2025, with the remaining principal due on the maturity date, or the Buyers may convert the 2024 Notes into shares of common stock of the Company at a conversion rate of 1,333.33 shares of common stock per $1,000 of principal for the first $3,000,000 of principal, and a conversion rate of 945.0992 shares of common stock per $1,000 of principal for the remaining principal. On December 19, 2024, the 2024 Notes were amended to increase the portion of principal that is subject to the higher conversion rate of 1,333.33 shares of commons stock per $1,000 of principal from $3,000,000 to $5,000,000. The Company analyzed the embedded conversion feature of the 2024 Notes for derivative accounting considerations under ASC 815-15, “Derivatives and Hedging,” and determined that it did not qualify to be bifurcated and accounted for as a derivative liability. For the three months ended December 31, 2024, amortization of the debt discount of the 2024 Notes totaled $0.4 million.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

The Company evaluated the amendment to the Purchase Agreement and concluded it was required to be accounted for as a troubled debt restructuring under ASC 470-60, “Troubled Debt Restructurings by Debtors,” as a concession had been granted to the Company. Per ASC 470-60, the carrying value of the Notes remained the same as before the amendment, reduced only by the fair value of the common shares issued to partially settle the Notes. No gain was recognized as the future undiscounted cash flows of the restructured Notes did not exceed the carrying amount of the Notes, with the effect of the restructuring accounted for prospectively through the revised effective interest rate of 50.73%.

The table below presents the net carrying amounts of the 2024 Notes as of:

	December 31, 2024
Principal outstanding	$	12,000,000
Debt discount		(2,243,790	)
Amortization of debt discount		409,167
Net carrying value	$	10,165,377

The table below presents the maturities of notes payable as of December 31, 2024:

Schedule of Maturities of Notes Payable


December 31, 2024	$	12,000,000
Less: unamortized debt discount and issuance costs		(1,834,623	)
Total notes payable	$	10,165,377

Notes payable, current	$	10,165,377
Notes payable, non-current	$	-

12. Leases

A lease provides the lessee the right to control the use of an identified asset for a period in exchange for consideration. Operating lease right-of-use assets (“RoU assets”) are presented within the asset section of the Company’s consolidated balance sheets, while lease liabilities are included within the liability section of the Company’s consolidated balance sheets at December 31, 2024 and June 30, 2024.

RoU assets represent the Company’s right to use an underlying asset for the lease term and operating lease liabilities represent the Company’s obligation to make lease payments arising from the lease. The Company determines if an arrangement is a lease at inception. RoU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Most operating leases contain renewal options that provide for rent increases based on prevailing market conditions. The terms used to calculate the RoU assets for certain properties include the renewal options that the Company is reasonably certain to exercise.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

The discount rate used to determine the commencement date present value of lease payments is the interest rate implicit in the lease, or when that is not readily determinable, the Company estimates a rate of 8.0% for the three months ending December 31, 2024 and 2023, based primarily on historical lending agreements. RoU assets include lease payments required to be made prior to commencement and exclude lease incentives. Both RoU assets and the related lease liability exclude variable payments not based on an index or rate, which are treated as period costs. The Company’s lease agreements do not contain significant residual value guarantees, restrictions, or covenants.

The Company occupies office facilities under lease agreements that expire at various dates, many of which do not exceed a year in length. Total operating lease costs for the three months ended December 31, 2024 and 2023, were each approximately $0.1 million. The Company does not have any finance leases as of December 31, 2024 and 2023.

As of December 31, 2024, current lease liabilities of $0.1 million are included in “Accounts payable and accrued liabilities” on the consolidated balance sheets. The table below presents total operating lease RoU assets and lease liabilities at December 31, 2024 and June 30, 2024:

	December 31, 2024		June 30, 2024
Operating lease right-of-use asset	$	357,431	$	42,103
Operating lease liabilities	$	359,015	$	54,304

The table below presents the maturities of operating lease liabilities as of December 31, 2024:


December 31, 2025	$	133,413
December 31, 2026		139,011
December 31, 2027		132,130
Total lease payments		404,554
Less: discount		(45,539	)

Total operating lease liabilities	$	359,015

Operating lease liabilities, current	$	108,600
Operating lease liabilities, non-current	$	250,416

The table below presents the weighted average remaining lease term for operating leases and the weighted average discount rate used in calculating operating lease right-of-use asset as of December 31, 2024.

Weighted average lease term (years)			2.83
Weighted average discount rate			8.00	%

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

13. Stockholders’ Equity

Preferred Stock

The Company’s amended and restated articles of incorporation authorize shares of preferred stock and provide that shares of preferred stock may be issued from time to time in one or more series. The Company’s board of directors (the “Board of Directors”) is authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. The Board of Directors is able to, without stockholder approval, issue shares of preferred stock with voting and other rights that could adversely affect the voting power and other rights of the holders of the common stock and could have anti-takeover effects. The ability of the Board of Directors to issue shares of preferred stock without stockholder approval could have the effect of delaying, deferring or preventing a change of control of the Company or the removal of existing management.

To date, the Company has authorized a total of 1,666,667 shares of preferred stock. Of this amount the Company has designated a total of 233,334 shares to four classes of preferred stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock. As of December 31, 2024 and June 30, 2024, there were 5 and nil shares of Series D Preferred Stock issued and outstanding. A description of each class of preferred stock is listed below.

On September 16, 2024, the Company entered into a Subscription and Investment Representation Agreement with Ryan Melsert, its Chief Executive Officer, who is an accredited investor, pursuant to which the Company agreed to issue and sell five (5) shares of the Company’s Series D Preferred Stock, par value $0.001 per share, to Mr. Melsert for an aggregate purchase price of $100, or $20 per share of Series D Preferred Stock. The sale closed on September 16, 2024. The Series D Preferred Stock is not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company. The Series D Preferred Stock has no rights with respect to distribution of assets of the Company, including upon a liquidation, bankruptcy, reorganization, merger, acquisition, sale, dissolution or winding up of the Company. Each share of Series D Preferred Stock had 12,000,000 votes and voted together with the outstanding shares of the Company’s common stock as a single class exclusively with respect to a proposal to amend the Company’s articles of incorporation, as amended, to increase the number of authorized shares of common stock of the Company. The Series D Preferred Stock was voted, without action by the holder, on such proposal in the same proportion, and in the same manner, as shares of common stock are voted by the shareholders and in no other manner. The Series D Preferred Stock has no other voting rights except as otherwise authorized by the Nevada Revised Statutes.

The Series D Preferred Stock shall be redeemed in whole, but not in part, at any time (i) if such redemption is ordered by the Board of Directors in its sole discretion or (ii) automatically upon the effectiveness of the amendment to the articles of incorporation, as amended, implementing an increase in the number of authorized shares of common stock of the Company, which occurred on November 14, 2024. Upon such redemption, the holder of the Series D Preferred Stock received consideration of $100. Accordingly, as the Series D Preferred Stock is subject to possible redemption, it is presented as temporary equity, outside of stockholders’ equity, at its redemption amount on the condensed consolidated balance sheets.

Subsequent to the Company’s annual meeting on November 13, 2024, the Company redeemed the Series D Preferred Stock for $100.

Series A Preferred Stock

The Company has 33,334 shares of Series A Preferred Stock authorized with a par value of $0.001 per share. The Company had nil shares of Series A Preferred Stock issued and outstanding on December 31, 2024 and June 30, 2024.

Series B Preferred Stock

The Company has 133,334 shares of Series B Preferred Stock authorized with a par value of $10.00 per share. The Company had nil shares of Series B Preferred Stock issued and outstanding on December 31, 2024 and June 30, 2024.

Series C Preferred Stock

The Company has 66,667 shares of Series C Preferred Stock authorized with a par value of $10.00 per share. The Company had nil shares of Series C Preferred Stock issued and outstanding on December 31, 2024 and June 30, 2024.

Series D Preferred Stock

The Company has 5 shares of Series D Preferred Stock authorized with a par value of $0.001 per share. The Company had nil shares of Series D Preferred Stock issued and outstanding on December 31, 2024 and June 30, 2024.

Common Stock

In November 2024, the Company’s shareholders approved and adopted an amendment to the articles of incorporation to increase the number of authorized shares of the Company’s common stock from 80,000,000 to 250,000,000. As of December 31, 2024, the Company has 250,000,000 shares of common stock authorized, with a par value of $0.001 per share.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Six months ended December 31, 2024:

During the period, the Company issued 1,426,620 common shares upon vesting of share-based awards.

On July 22, 2024, the Board of Directors authorized and approved to extend the expiration date to April 30, 2025 for 600,000 certain warrants with an exercise price of $1.125 issued in connection with a previous equity offering which were previously scheduled to expire on October 31, 2024. Of the 600,000 warrants, 200,000 warrants are held by Ryan Melsert, Chief Executive Officer. The modification of the warrants resulted in incremental fair value of $0.1 million as of the modification date, of which less than $0.1 million was recognized as stock-based compensation expense for those warrants held by the Chief Executive Officer and the remainder as a deemed dividend per the requirements of ASC 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Equity.” The Company utilized a Black-Scholes option-pricing model to determine the incremental fair value with assumptions including volatility of 100.47% and a risk-free rate of 5.06%.

On August 1, 2024, the Company agreed to sell in a private placement 53 Group A Units (defined below) to several accredited investors and 23 Group B Units to the Company’s new Chief Operating Officer, to an immediate family member of the Chief Executive Officer, and to two current employees, a portion of which was rescinded on November 12, 2024 (see Note 6), resulting in the sale of a total of only 18 Group A Units and 23 Group B Units in such private placement. Each “Group A Unit” consists of 25,000 shares of Common Stock, 25,000 Series A warrants with a five-year term to purchase Common Stock (“Series A Warrants”) and 25,000 Series B Warrants with an 18-month term to purchase Common Stock (collectively with the Series A Warrants, the “Warrants”) with a purchase price of $25,000 per Unit; each “Group B Unit” consists of 19,531 shares of Common Stock and 39,062 Series A Warrants with a five-year term and a purchase price of U.S. $25,000 per Unit. The Company received an initial payment of approximately $1.9 million but after the recission retained only an aggregate purchase price of $1.0 million.

Upon issuance of the common stock and warrants in the private placement, the Company concluded that it had insufficient authorized shares to settle the warrants sold as well as certain previously issued warrants (see Note 6). As the warrants were therefore accounted for as derivative liabilities and remeasured at fair value each reporting period (see Note 6), the Company allocated the proceeds first to the warrants with any residual proceeds allocated to the common shares. A day-one loss is recognized to the extent the recognized fair value of common shares and warrants exceeds the proceeds received.

During the six months ended December 31, 2024, the Company issued 1,936,576 common shares to the Note holders pursuant to the debt conversion option in lieu of cash payment of $1.6 million (see Note 11). The fair value of the common shares issued of $1.9 million was recorded in additional paid-in capital for this transaction.

During the six months ended December 31, 2024, the Company recognized stock-based compensation expense of $9.5 million, which was an increase to additional paid-in capital of $8.8 million and an increase to the equity compensation liability of less than $0.1 million. Stock-based compensation expense also included $0.7 million related to the excess fair value related to warrants issued to the insiders and the incremental fair value from modification of certain warrants discussed above.

On November 13, 2024, the Company’s shareholders approved the Company’s 2024 Employee Stock Purchase Plan (the “2024 ESPP”). The 2024 ESPP provides the Company’s employees with the ability to contribute a portion of their earnings to purchase the Company’s shares of common stock. Pursuant to the terms of the 2024 ESPP, the Company’s executive officers and all of its other employees will be allowed to participate in the 2024 ESPP. During the period, employees purchased 177,440 shares under the 2024 ESPP with an aggregate purchase price of $0.1 million.

On December 23, 2024, the Company entered into a securities purchase agreement with two institutional investors including the Buyers (see Note 11) for the purchase and sale of (i) 5,000,000 shares its common stock, and (ii) warrants exercisable for up to an aggregate of 5,000,000 shares of common stock for a combined offering price of $1.00 per share and accompanying warrant. The warrants have an exercise price of $1.10 per share, are exercisable immediately from the date of issuance and expire five years from the initial exercise date.

On December 27, 2024, the Company entered into another securities purchase agreement with two institutional investors including the Buyers for the purchase and sale of (i) 3,773,586 shares of its common stock, and (ii) warrants exercisable for up to an aggregate of 3,773,586 shares of common stock for a combined offering price of $2.65 per share and accompanying warrant. The warrants have an exercise price of $2.80 per share, will be exercisable immediately from the date of issuance and will expire five years from the initial exercise date. The Company received total proceeds from both December 2024 securities purchase agreements of $15.0 million, net of offering costs of $1.1 million, which were recorded to additional paid-in capital as the Company determined the warrants met the equity classification criteria.

The Company had the following potentially dilutive shares outstanding as of December 31:

	2024		2023
Convertible notes		13,282,344		1,942,363
Warrants		16,138,037		5,731,666
Share awards outstanding		8,052,791		2,871,252
Total potentially dilutive		37,473,172		10,545,281

14. Share Purchase Warrants

During the six months ended December 31, 2024, there were 12,518,188 total warrants issued. The Company issued 3,548,426 warrants pursuant to the Private Placement (see Note 13), of which 898,426 warrants were purchased by employees of the Company and 1,750,000 warrants were cancelled per the rescission agreement executed with certain investors in November 2024 (see Note 6). The Company also issued 8,773,586 warrants in December 2024 in connection with the securities purchase agreements (see Note 13). The Company issued 196,176 warrants under its compensation arrangements (see Note 15).

	Number of Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value

Balance, June 30, 2024		6,928,758		$	12.95
Granted		3,548,426			1.01
Exercised		-			-
Expired		(1,082,715	)		12.02
Balance, September 30, 2024		9,394,469		$	8.55
Granted		8,969,762			1.90
Exercised		-			-
Rescinded		(1,750,000	)		1.00
Expired		(476,194	)		10.50
Balance, December 31, 2024		16,138,037		$	5.61		4.12	$	-
Exercisable, December 31, 2024		15,365,150		$	4.53		4.08	$	-

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

15. Equity Compensation Awards

The Company has established the 2021 Retention Plan (“the Retention Plan”) to issue shares in the effort to retain key executives, directors, and employees. The Retention Plan allows for several different types of awards to be granted, including but not limited to, restricted share units and restricted share awards, collectively referred to as “share awards”. Share awards generally have the same expense characteristics under US GAAP and generally vest over a four-year period at a rate of 25% per annum.

Under the Retention Plan, the Company is authorized to issue shares of common stock to employees and non-employees up to ten percent (10%) of the total number of shares of common stock outstanding as of December 31, 2022, on a fully diluted basis. The Company adjusts the authorized shares under the plan each December 31, while the Retention Plan remains in effect. During the three months ended December 31, 2024, the Company granted 5.8 million share awards.

The table below reflects the share award activity for the period ended December 31, 2024:

	Units			Weighted- Average Grant Date Fair Value per Unit

Unvested share awards at June 30, 2024		3,428,604		$	5.02
Granted		185,742			1.00
Vested		(410,504	)		4.10
Forfeitures		(26,875	)	$	5.22
Unvested share awards at September 30, 2024		3,176,967		$	4.90
Granted		5,822,024			0.96
Vested		(924,430	)		2.43
Forfeitures		(21,770	)	$	6.76
Unvested awards at December 31, 2024		8,052,791		$	2.33

As awards are granted, stock-based compensation equivalent to the fair market value of the underlying common stock on the date of grant is expensed over the requisite service period, generally four years with a maximum contractual term of ten years, using the graded vesting attribution method as acceptable under ASC 718, “Compensation-Stock Compensation.” The Company accounts for forfeitures as they occur. The fair value of share awards that vested during the quarter ended December 31, 2024 totaled $1.0 million.

The Company recognized stock-based compensation expense of $9.5 million and $7.7 million for the six months ended December 2024 and 2023, respectively. As of December 31, 2024 and June 30, 2024, the equity compensation liability totaled nil and $0.4 million related to warrants and RSUs awarded to officers of the Company, respectively, where the performance target had not yet been achieved by employees and officers and therefore the number of warrants and RSUs underlying the awards was not yet fixed.

As of December 31, 2024, there were approximately $20.6 million of unamortized expenses relating to outstanding equity compensation awards to be recognized over a remaining weighted-average period of 3.2 years.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

The table below presents the stock-based compensation expense per respective line item on the condensed consolidated statements of operations for the six months ended December 31:

	2024		2023

Cost of goods sold	$	267,449	$	-
General and administrative		6,836,740		4,083,070
Research and development		2,295,427		2,659,061
Exploration		102,417		949,380
Total stock-based compensation	$	9,502,030	$	7,691,511

Executive officers and selected other key employees are eligible to receive common share performance-based awards, as determined by the Board of Directors and CEO. The payouts, in the form of share awards, vary based on the degree to which corporate operating objectives are met. These performance-based awards typically include a service-based requirement, which is generally four-years.

16. Supplemental Statement of Cash Flow Disclosures

For the six months ended December 31:

	2024		2023

Supplemental disclosures:

Interest paid	$	4,575	$	14,462

Non-cash investing and financing activities:

Purchases of property and equipment accrued in current liabilities		225,104		-
Deposits capitalized as investing activities		-		27,103,351
Right-of-use asset obtained in exchange for lease liability		367,643		-
Debt payment satisfied with common shares		1,742,580		-
Payable recognized upon rescission of subscription agreement		875,000		-

17. Commitments and Contingencies

From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Except as otherwise identified herein, management is currently not aware of any such legal proceedings or claims that could have, individually or in aggregate, a material adverse effect on our business, financial condition, or operating results.

Operating Leases

The Company leases its principal office location in Reno, Nevada. It also leases lab space at the University of Nevada, Reno on short term leases. The principal office location lease expires on November 30, 2027 and the Lab leases expire on November 30, 2025. Consistent with the guidance in ASC 842, the Company has recorded the principal office lease in its condensed consolidated balance sheet as an operating lease. For further information on operating lease commitments, see Note 12 – Leases.

Financial Assurance:

Nevada and other states, as well as federal regulations governing mine operations on federal land, require financial assurance to be provided for the estimated costs of mine reclamation and closure, including groundwater quality protection programs. The Company has satisfied financial assurance requirements using a combination of cash bonds and surety bonds. The amount of financial assurance the Company is required to provide will vary with changes in laws, regulations, reclamation and closure requirements, and cost estimates. At December 31, 2024, the Company’s financial assurance obligations associated with U.S. mine closure and reclamation/restoration cost estimate totaled $0.1 million, for which the Company is legally required to satisfy its financial assurance obligations for its mining properties in Tonopah, Nevada. The Company was previously released of all of its liability in the Railroad Valley region of Nevada.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and related notes in “Item 1. Condensed Consolidated Financial Statements.” References in this report to “American Battery,” the “Company,” “we,” “our” and “us” are references to American Battery Technology Company and its subsidiaries.

Forward-Looking Statements

We make forward-looking statements in this report and may make such statements in future filings with the Securities and Exchange Commission, or SEC. We may also make forward-looking statements in our press releases or other public or shareholder communications. Our forward-looking statements are subject to risks and uncertainties and include information about our current expectations and possible or assumed future results of our operations. When we use words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “could,” “plan,” “potential,” “predict,” “forecast,” “project,” “intend,” “is focused on” or similar expressions, or make statements regarding our intent, belief, or current expectations, we are making forward-looking statements. Our forward-looking statements also include, without limitation, statements about our liquidity and capital resources; our ability to continue as a going concern; our ability to successfully execute on our business strategy; our ability to raise additional capital and statements regarding our anticipated future financial condition, operating results, cash flows and business plans.

While we believe our forward-looking statements are reasonable, you should not place undue reliance on any such forward-looking statements, which are based on information available to us on the date of this report or, if made elsewhere, as of the date made. Because these forward-looking statements are based on estimates and assumptions that are subject to significant business, economic and competitive uncertainties, many of which are beyond our control or are subject to change, actual results could be materially different. Factors that might cause such a difference include, without limitation, the risks and uncertainties discussed in this report, “Item 1A — Risk Factors” in our Form 10-K for the year ended June 30, 2024 and from time to time in our other reports filed with the SEC.

Other factors not currently anticipated may also materially and adversely affect our results of operations, cash flows and financial position. There can be no assurance future results will meet expectations. Forward-looking statements speak only as of the date of this report and we expressly disclaim any intent to update or alter any statements whether as a result of new information, future events or otherwise, except as may be required by applicable law.

Overview

American Battery Technology Company (the “Company”) is an integrated critical battery materials company within the lithium–ion battery industry that is working to increase the domestic U.S. production of battery materials, such as lithium, nickel, cobalt, and manganese through its exploration of new domestic-US primary resources of battery metals, development and commercialization of new technologies for the extraction of these battery metals from primary resources, and commercialization of an internally developed integrated process for the recycling of lithium–ion batteries. Through this three–pronged approach the Company is working to both increase the domestic production of these battery materials, and to ensure spent batteries have their elemental battery metals returned to the domestic manufacturing supply chain in an economical, environmentally-conscious, closed–loop fashion.

To implement this business strategy, the Company has constructed its first integrated lithium–ion battery recycling facility, which takes in waste and end–of–life battery materials from the electric vehicle, stationary storage, and consumer electronics industries. The ramp-up and operations of this facility are of the highest priority to the Company, and as such it has significantly increased the resources devoted to its execution including the further internal hiring of technical staff, expansion of laboratory facilities, and purchasing of equipment. The Company has been awarded a competitively bid grant from the U.S. Advanced Battery Consortium to support a $2 million project to accelerate the development and demonstration of the technologies within this integrated lithium–ion battery recycling facility. The Company has also been awarded an additional grant from the DOE to support a $20 million project under the Bipartisan Infrastructure Law to validate, test, and deploy three next-generation disruptive advanced separation and processing recycling technologies.

Additionally, the Company is accelerating the demonstration and commercialization of its internally developed low–cost and low–environmental impact processing train for the manufacturing of battery grade lithium hydroxide from Nevada–based sedimentary claystone resources. The Company has been awarded a competitive grant from the DOE’s Advanced Manufacturing and Materials Technologies Office through the Critical Materials Innovation program to support a $4.5 million project for the construction and operation of a multi–ton per day integrated continuous demonstration system to support the scale–up and commercialization of these technologies. The Company has also been awarded an additional grant award under the Bipartisan Infrastructure Law to support a $115.5 million project to design, construct, and commission a first-of-kind commercial-scale refinery to produce 30,000 MT of battery-grade lithium hydroxide per year from this resource.

ABTC has completed the construction and commissioning of its claystone to lithium hydroxide (LiOH) pilot plant, marking a significant milestone in the commercialization of its internally-developed processes to access an unrealized domestic primary lithium resource. The construction and commissioning of this pilot plant enables ABTC to demonstrate its technologies for accessing the lithium housed in its unconventional resource, Tonopah Flats Lithium Project (TFLP), in an integrated and continuous system, and to generate large amounts of battery grade lithium hydroxide for delivery to customers for qualifications and evaluation. The construction and operation of this pilot demonstration plant are supported by a competitively awarded grant from the DOE for this $4.5 million effort. Product from the pilot plant is being sent for analysis to confirm and validate the resource.

ABTC has filed an amended Initial Assessment for its Tonopah Flats Lithium Project (TFLP). The TFLP is one of the largest identified lithium resources in the U.S., and while initial pit designs and economic analyses in previous assessments evaluated the full resource, this updated Initial Assessment utilizes a commercialization pathway with a more rigorous mine plan that contemplates utilization of only Measured and Indicated Mineral Resources, and excludes Inferred Mineral Resources, to supply the planned commercial-scale lithium hydroxide refinery. This commercialization pathway allows for an engineered phased development, with improved access to the higher quality portions of the resource, and at improved project economics.

On March 28, 2024, ABTC was selected for an approximately $19.5 million tax credit through the Qualifying Advanced Energy Project Credits program (48C). This tax credit was granted by the U.S. Department of Treasury Internal Revenue Service following a highly competitive technical and economic review process performed by the DOE, which evaluated the feasibility of applicant facilities to advance America’s buildout of globally competitive critical material recycling, processing, and refining infrastructure. This $19.5 million tax credit can be utilized both for the reimbursement of capital expenditures spent to date, and also for equipment and infrastructure for additional value-add operations at ABTC’s battery recycling facility in the Tahoe-Reno Industrial Center (TRIC) in Storey County, Nevada. As of December 31, 2024, the Company has incurred qualifying expenditures for this tax credit but will not recognize any amounts until it has reasonable assurance of compliance with the relevant standards. The Company intends to sell the credit in order to monetize it’s value.

Also on March 28, 2024, ABTC was selected for an additional $40.5 million tax credit through the Qualifying Advanced Energy Project Credits program (48C) to support the design and construction of a new, next-generation, commercial battery recycling facility to be located in the United States. As with ABTC’s initial $19.5 million tax credit under the 48C program supporting the construction and buildout of its battery recycling facility in Nevada, this additional award was granted by the U.S. Department of Treasury Internal Revenue Service following a highly competitive technical and economic review process performed by the DOE, which evaluated the feasibility of applicant facilities to advance America’s buildout of globally competitive critical material recycling, processing, and refining infrastructure. As of December 31, 2024, the Company has not incurred any qualifying expenditures towards this tax credit.

Financial Highlights:

	●	Revenues were $332,000 in the three months ended December 31, 2024, following the Company’s initial recognition of revenues in the fourth quarter of fiscal 2024.
	●	Cost of goods sold was $3.3 million in the three months ended December 31, 2024, include in this amount are non-cash items such as depreciation expense of $1.1 million and stock-based compensation of $0.1 million leaving cash cost of goods sold of $2.1 million.
	●	On September 23, 2024, the Company was selected for a new highly competitive grant from the U.S. DOE for $150 million and on December 18, 2024, the Company received a contracted grant award for $144 million of federal investment to construct a second lithium-ion battery recycling facility.
	●	Government grant reimbursement was $2.3 million for the six months ended December 31, 2024 compared to $1.7 million during the same period of the prior year. Out of the $2.3 million in grant funding for the six months ended December 31, 2024, $0.6 million was recorded as an offset to fixed assets, as reimbursements related to equipment purchases, and $1.7 million was recorded as an offset to research and development costs within the condensed consolidated statement of operations.
	●	As of December 31, 2024, the Company had total cash on hand of $20.6 million of which $15.6 million was available and $5.0 is restricted.
	●	Cash used in operations for the six months ended December 31, 2024 was $12.8 million, compared to $7.4 million of cash used in operations for the six months ended December 31, 2023.
	●	On November 14, 2024, the Company issued a new series of senior convertible notes (the “2024 Notes”) in the aggregate principal amount of $12 million.
	●	In December 2024, the Company entered into two registered direct offerings, as described below, for a total amount of $15 million in gross proceeds.

Results of Operations for the Three Months Ended December 31, 2024 and 2023

Revenue

During the three months ended December 31, 2024, our revenue was $0.3 million. This is related to the sale of our recycled products produced from recycling operations and followed our initial revenue generated by the Company in the fourth quarter of fiscal 2024.

Cost of Goods Sold

Cost of goods sold during the three months ended December 31, 2024 was $3.3 million. After the removal of non-cash items of $1.2 million such as depreciation expense of $1.1 million and stock-based compensation of $0.1 million, cash cost of goods sold was $2.1 million. The high cost of goods sold is related to the depreciation of the recycling facility fixed assets which is time based, and labor and overhead costs. We expect these costs to continue to rise on an absolute basis but will be reduced as a percentage of revenue as we scale our production and sales and gain efficiencies in the production process.

Management uses certain non-GAAP metrics to evaluate our operating and financial results. We believe the presentation of non-GAAP results is useful to investors for analyzing business trends as well as to view the results from management’s perspective. Non-GAAP Cost of Goods sold excludes certain non-cash charges including depreciation expense and stock-based compensation. Non-GAAP results have limitations as an analytical tool, and you should not consider them in isolation or as a substitute for our results reported under GAAP.

Operating Expenses

During the three months ended December 31, 2024, the Company incurred $10.8 million of operating expenses compared to $8.8 million during the three months ended December 31, 2023.

General and administrative expenses consist of personnel, stock-based compensation, office expenses, legal, recruitment, business development, public relations, and general facility expenses. For the three months ended December 31, 2024 and 2023, general and administrative expenses were $7.7 million and $4.4 million, respectively. The increase of $3.3 million in the current period primarily related to increased employee stock-based compensation, personnel costs due to increased headcount, and external, audit and insurance costs.

Research and development expenses consist primarily of laboratory leases, supplies, personnel, stock-based compensation, and employee benefits. Research and development expenses for the three months ended December 31, 2024 and 2023 were $2.9 million and $3.6 million, respectively. The decrease in the current period is primarily due to allocation of a portion of such costs to inventory and cost of goods sold as part of phase 1 recycling operations coming online in the fourth quarter of fiscal 2024. Research and development expenses are partially offset by federal grant funds for awards the Company has contracted with various federal agencies. The Company recognized an offset to its research and development costs of $1.8 million and $0.7 million related to these awards for the three months ended December 31, 2024 and 2023 respectively.

Exploration costs consist primarily of drilling, assay, claim fees, personnel, stock-based compensation, office and warehouse, travel, and other costs related to exploration of claims in central Nevada. Exploration expenses totaled $0.2 million for the three months ended December 31, 2024 compared to $0.8 million during the same period in the prior year. The decrease quarter-over-quarter resulted principally from higher costs in the prior year related to drilling, assaying and engineering to further define and potentially upgrade the geological classification of the mineral rights.

Other Income (Expense)

During the three months ended December 31, 2024, the Company recorded other income of $0.4 million, consisting of income of $1.1 million resulting from a change in the fair value of liability classified financial instruments partially offset by expense of $0.7 million for amortization of debt financing costs.

Results of Operations for the Six Months Ended December 31, 2024 and 2023

Revenue

During the six months ended December 31, 2024, our revenue was $0.5 million. This is related to the sale of our recycled products produced from recycling operations and followed our initial revenue generated by the Company in the fourth quarter of fiscal 2024. The materials were sold to several customers who took delivery at our plant . Approximately $0.2 million of revenue is attributed to materials that will remain at our plant to be further processed when phase two of the plant is complete. The customer for these materials has full ownership, rights and obligations associated with the materials, including cost of storage.

Cost of Goods Sold

Cost of goods sold during the six months ended December 31, 2024 was $5.8 million. After the removal of non-cash items of $2.4 million such as depreciation expense of $2.2 million and stock-based compensation of $0.2 million, cash cost of goods sold was $3.4 million. The high cost of goods sold is related to the depreciation of the recycling facility fixed assets, which is time based, and the finalization of the production process. We expect these costs to continue to rise on an absolute basis but will be reduced as a percentage of revenue as we scale our production and sales and gain efficiencies in the production process.

Operating Expenses

During the six months ended December 31, 2024, the Company incurred $18.3 million of operating expenses compared to $16.8 million during the six months ended December 31, 2023.

General and administrative expenses consist of personnel, stock-based compensation, office, legal, recruitment, business development, public relations, and general facility expenses. For the six months ended December 31, 2024, general and administrative expenses were $12.7 million, an increase of $5.2 million over the same period in the prior year primarily related to increased employee stock-based compensation, personnel costs, and audit and insurance costs.

Research and development expenses consist primarily of laboratory leases, supplies, personnel, stock-based compensation, and employee benefits. Research and development expenses for the six months ended December 31, 2024 and 2023 were $5.0 million and $7.2 million, respectively. The decrease in the current period is primarily due to allocation of a portion of such costs to inventory and cost of goods sold as part of phase 1 recycling operations coming online in the fourth quarter of fiscal 2024. These costs are partially offset by federal grant funds for awards that it has contracted with various federal agencies. The Company recognized an offset to its research and development costs of $2.3 million and $1.2 million related to these awards for the six months ended December 31, 2024 and 2023 respectively.

Exploration costs consist primarily of drilling, assay, claim fees, personnel, stock-based compensation, office and warehouse, travel, and other costs related to exploration of claims in central Nevada. Exploration expenses totaled $0.7 million for the six months ended December 31, 2024 compared to $2.2 million during the same period in the prior year. The decrease year-over-year resulted principally from higher costs in the prior year related to drilling, assaying and engineering to further define and potentially upgrade the geological classification of the mineral rights.

Other Income (Expense)

During the six months ended December 31, 2024, the Company recorded other expense of $1.5 million, including $1.9 million for amortization of debt financing costs, a $0.7 million loss on debt extinguishment, and $0.6 million loss on private placement. These expenses were partially offset by other income of $0.9 million for change in fair value of liability classified instruments and $0.7 million for change in fair value of derivative liability.

Liquidity and Capital Resources

At December 31, 2024, the Company had cash of $20.6 million (of which $15.6 million was available and $5.0 million is restricted) and total assets of $88.3 million compared to available cash of $7.0 million and total assets of $77.7 million at June 30, 2024. On December 23, 2024, the Company issued 5,000,000 shares of common stock and warrants exercisable for up to 5,000,000 shares of common stock in exchange for gross proceeds of $5.0 million (the “First Offering”). On December 27, 2024, the Company issued 3,773,586 shares of common stock and warrants exercisable for up to 3,773,586 shares of common stock in exchange for gross proceeds of $10.0 million (the “Second Offering” and, together with the First Offering, the “Offerings”). The increase of cash is due to proceeds of approximately $15 million from the Offerings and approximately $12 million from the issuance of the 2024 Notes, offset by normal transactional activities related to plant production and paydown of debt obligations.

The Company had total current liabilities of $17.7 million at December 31, 2024, compared to $15.8 million at June 30, 2024. The increase is related to the issuance of the 2024 Notes, offset by some paydown of debt, and the timing of payments for accounts payable and accrued expenses.

As of December 31, 2024 the Company had working capital of $12.8 million compared to $2.6 million at June 30, 2024. The positive working capital at the end of both periods results from the classification of $8.4 million of held-for-sale assets as current at December 31, 2024 and June 30, 2024 and the increase in cash due to proceeds from the Offerings and the issuance of the 2024 Notes. Absent the held-for-sale classification of certain assets, the working capital would have been a positive $4.4 million and a deficiency of $5.8 million at December 31, 2024 and June 30, 2024, respectively.

Based on our current operating plan, unless we generate income from the operations of our facilities or raise additional capital (debt or equity), it is possible that we will be unable to maintain our financial covenants under our existing debt agreements. If such covenant violations are not waived by the holders of the Notes and the 2024 Notes, it would result in an event of default, causing an acceleration of the outstanding balances. If we do raise additional capital through public or private equity offerings, as opposed to debt issuances, the ownership interest of our existing stockholders may be diluted.

Cash Flows

For the six months ended December 31:

	2024			2023
Cash used in operating activities	$	(12,815,978	)	$	(7,418,700	)
Cash used in investing activities		(1,509,581	)		(10,868,460	)
Cash provided by financing activities		27,947,535			23,613,794
Net increase in cash during the period		13,621,976			5,326,635

Cash from Operating Activities.

During the six months ended December 31, 2024, the Company used $12.8 million of cash for operating activities, compared to $7.4 million used during the six months ended December 31, 2023. In both periods, the cash used has supported an increased scale of operations including increased employee headcount and personnel costs, increased production, and increased administrative costs related to insurance, legal and accounting.

Cash from Investing Activities

During the six months ended December 31, 2024, the Company used cash in investing activities of $1.5 million for acquisition of property and equipment for its recycling facilities. This is in comparison to cash used in investing activities of $10.9 million for the six months ended December 31, 2023. The decrease is due to the Company’s purchasing more equipment in the beginning stages of the recycling plant build-out in the prior year.

Cash from Financing Activities

During the six months ended December 31, 2024, the Company had cash provided by financing activities of $27.9 million, compared to $23.6 million provided during the six months ended December 31, 2023. The Company has relied on equity and debt financings to support its increased operating activities, the ramp up of the recycling plant, development of the lithium ore pilot plant, and upgrades to the geological category of its Tonopah claims through additional studies and assessments.

The Company had proceeds from equity and debt financings of $23.5 million in the six months ended December 31, 2024 compared to $14.7 million in the prior year period. The increase in cash provided by equity financings in the six months ended December 31, 2024 is related to the sale of 5,938,786 shares of common stock pursuant to its at-the-market (“ATM”) sales agreement for total proceeds of $6.3 million and proceeds from the Offerings; partially offset by paydowns of previous secured convertible notes.

Working Capital

	December 31, 2024		June 30, 2024
Current assets	$	30,484,727	$	18,406,048
Current liabilities		17,691,807		15,798,298
Working capital		12,792,920		2,607,750

Future Financing

The Company will continue to rely on sales of our common shares, debt, or other financing to fund our business operations as needed beyond any revenue generated from internal operations and the government tax credits and grants we have been awarded. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of the securities or arrange for debt or other financing to fund planned operating activities, acquisitions and exploration activities.

Critical Accounting Estimates

Our condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors and adjust those estimates and assumptions when facts and circumstances dictate. Actual results could differ materially from those estimates and assumptions.

While some of our significant accounting policies are more fully described in Note 2, “Summary of Significant Accounting Policies” in the notes to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q, all our critical accounting policies and significant estimates are detailed in our Annual Report on Form 10-K for the year ended June 30, 2024.

Off-Balance Sheet Arrangements

As of December 31, 2024, we had no off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not Applicable.

Item 4. Controls and Procedures

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended (the “Exchange Act”). Disclosure controls and procedures are controls and other procedures designed to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act (15 U.S.C. 78a et seq.) is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

The Company’s management, with the participation of the Chief Executive Officer and Chief Financial Officer of the Company, carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of December 31, 2024, the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of December 31, 2024, the Company’s disclosure controls and procedures are not effective, based on the material weaknesses described below.

Material Weakness in Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act). Management, with the participation of the principal executive officer and principal financial officer, under the oversight of our Board of Directors, assessed the effectiveness of our internal control over financial reporting as of December 31, 2024 based on the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013 Framework). Based on this assessment, management concluded that, as of December 31, 2024, our internal control over financial reporting was not effective, due to the material weaknesses in internal control over financial reporting, described below.

Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including the individuals serving as our principal executive officer and principal financial officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis.

The Company did not have a sufficient complement of personnel with appropriate technical expertise to perform an effective risk assessment. In addition, the Company did not maintain proper segregation of duties related to accounting processes. As a consequence, internal control deficiencies related to the design and operation of process-level controls were determined to be pervasive throughout the Company’s financial reporting processes. While these material weaknesses did result in immaterial misstatements of the Company’s consolidated financial statements, these material weaknesses create a reasonable possibility that a material misstatement of account balances or disclosures in the consolidated financial statements may not be prevented or detected in a timely manner. Therefore, we concluded that the deficiencies represent material weaknesses in the Company’s internal control over financial reporting and our internal control over financial reporting was not effective as of December 31, 2024.

Remediation Plan

During the fiscal year ended June 30, 2024, remediation efforts included removing accounting personnel access to both create and post a journal entry, moving the systems administration tasks to personnel outside of the accounting department, and adding review procedures by qualified personnel over complex accounting matters by way of engaging third-party professionals with whom to consult regarding complex accounting applications and valuations. However, there is no guarantee that these measures will remediate the material weaknesses described above.

In addition to the steps taken outlined above, in July 2024, we hired a new corporate controller with extensive experience in technical accounting, SEC reporting and internal control over financial reporting. In October 2024, we hired a senior accountant with public accounting and public company reporting experience, which will help to mitigate the segregation of duties weakness. We plan to continue to utilize an outside CPA firm for technical expertise and we plan to perform a complete risk assessment to update our control procedures. We expect these additional steps will help mitigate the technical expertise weakness, the segregation of duties weakness and identify any other areas of risk to be incorporated in our overall internal control plan. We expect to remediate these material weaknesses by the end of fiscal year 2025. The Company is currently conducting a diligent search for a permanent Chief Financial Officer with relevant and extensive experience in accounting and finance.

We are committed to ensuring that our internal control over financial reporting is designed and operating effectively. While we believe procedures are in place as of December 31, 2024 to address the material weaknesses, remediation steps are required to be in place and effective for an adequate period of time. We cannot provide assurance that such material weaknesses will be remediated, and we may discover additional material weaknesses that may require additional time and resources to remediate.

Changes in Internal Control over Financial Reporting

Except as noted above with respect to the completion of certain steps in the remediation plan, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the fiscal quarter covered by this Interim Report on Form 10–Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

We may be involved in certain routine legal proceedings from time to time before various courts and governmental agencies. We cannot predict the final disposition of such proceedings. We regularly review legal matters and record provisions for claims considered probable of loss. The resolution of these pending proceedings is not expected to have a material effect on our operations or consolidated financial statements in the period in which they are resolved.

Item 1A. Risk Factors

Our business is subject to various risks, including those described in Part I, Item 1A of our Annual Report on Form 10-K for the year ended June 30, 2024. There have been no changes to the risk factors set forth in our Annual Report on Form 10-K for the year ended June 30, 2024 under “Item 1A - Risk Factors” and in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 under “Item 1A – Risk Factors”. Additionally, the Trump Administration has issued numerous Executive Orders (“EOs”), including the Unleashing American Energy Executive Order on January 20, 2025, which requires an immediate pause in the disbursement of funds appropriated through the Inflation Reduction Act of 2022 during a 90-day review period. The Company is currently evaluating these EOs and other related memoranda to determine what, if any, impact they might have on awards selected or received from the DOE. This pause, or a similar pause, particularly if extended, could delay the timing of projects, and could have a material adverse impact on our business, financial condition, and results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Departure of Chief Financial Officer

On February 10, 2025, Paul McGarry notified the Company of his intent to step down as Interim Chief Financial Officer, effective February 21, 2025 (the “Retirement Date”). Mr. McGarry’s departure is not related to any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

Appointment of Interim Chief Financial Officer

On February 13, 2025, the Board of Directors of the Company appointed Jesse Deutsch to serve as Interim Chief Financial Officer of the Company, effective February 21, 2025. The Board of Directors of the Company previously initiated, and continues, a diligent search for Mr. Deutsch’s permanent replacement.

Mr. Deutsch, 60, previously served as the Company’s Chief Financial Officer from May 22, 2023 to January 31, 2025. Mr. Deutsch is returning to the Company out of retirement following Mr. McGarry’s departure in order to serve as the Company’s Interim Chief Financial Officer while the Company conducts its search for his permanent replacement. Mr. Deutsch has over 25 years of finance experience in world-class multinational corporations in the U.S. and abroad. He has led several businesses through transformative high-growth phases and has completed more than 75 M&A transactions with strategic partners. He joins the Company with nearly 20 years serving in the role as Chief Financial Officer with global brands such as Kraft Foods and Aramark Inc., and over the course of his tenure has served in executive financial leadership roles at companies such as Visa, and Philip Morris. Mr. Deutsch has in-depth experience in establishing transformative finance processes and has led large systems implementations. He has an MBA from New York University and a Bachelor of Science in economics from The Wharton School of the University of Pennsylvania.

There is no arrangement or understanding between Mr. Deutsch and any other persons, pursuant to which he was selected as Interim Chief Financial Officer. Mr. Deutsch has not engaged in any transaction, or any currently proposed transaction, in which the Company was or is to be a participant and the amount involved exceeds $120,000, and in which any related person had or will have a direct or indirect material interest. There are no family relationships between Mr. Deutsch and any director or executive officer of the Company.

On February 13, 2025, the Company entered into an Offer Letter (the “Offer Letter”) with Mr. Deutsch, pursuant to which Mr. Deutsch will be an at-will employee of the Company. Pursuant to the Offer Letter, Mr. Deutsch will receive an annual base salary of $280,000 and a one-time signing bonus of $25,000. The foregoing descriptions of the Offer Letter are qualified in their entirety by reference to the full text of the Offer Letter, a copy of which is filed as Exhibit 10.12 hereto, and the terms of which are incorporated by reference.

Item 6. Exhibits

The following exhibits are either provided with this Annual Report or are incorporated herein by reference:

Exhibit	Description	Filed Herein	Incorporated Date	By Form	Reference Exhibit
3.1	Certificate of Amendment to Articles of Incorporation		11/14/2024	8-K	3.1
4.1	Form of Senior Secured Convertible Note		12/13/2024	S-1	10.1
4.2	Form of Common Stock Purchase Warrant		12/23/2024	8-K	4.1
4.3	Form of Common Stock Purchase Warrant		12/27/2024	8-K	4.1
10.1	American Battery Technology Company 2024 Employee Stock Purchase Plan		12/02/2024	S-8	99.2
10.2	Offer Letter, by and between American Battery Technology Company and Jesse Deutsch, executed November 21, 2024		11/27/2024	8-K	10.1
10.3	Offer Letter, by and between American Battery Technology Company and Ryan Melsert, executed November 22, 2024		11/27/2024	8-K	10.2
10.4	Offer Letter, by and between American Battery Technology Company and Steven Wu, executed November 21, 2024		11/27/2024	8-K	10.3
10.5	Offer Letter, by and between American Battery Technology Company and Scott Jolcover, executed November 21, 2024		11/27/2024	8-K	10.4
10.6	Amendment to Securities Purchase Agreement, dated November 14, 2024, by and among American Battery Technology Company, High Trail Investments ON LLC and High Trail Special Situations LLC (including Form of Senior Secured Convertible Note)		12/13/2024	S-1	10.1
10.7	Amendment to Securities Purchase Agreement, dated December 20, 2024, by and among American Battery Technology Company, High Trail Investments ON LLC and High Trail Special Situations LLC	x
10.8	Form of Securities Purchase Agreement, dated as of December 19, 2024, among American Battery Technology Company and the investors named therein		12/23/2024	8-K	10.1
10.9	Amendment to Subsequently Purchased Notes, dated December 19, 2024, among American Battery Technology Company and the investors named therein		12/23/2024	8-K	10.2
10.10	Form of Securities Purchase Agreement, dated as of December 26, 2024, among American Battery Technology Company and the investors named therein		12/27/2024	8-K	10.1
10.11	DOE Grant Award DE-MS0000104, dated December 16, 2024	x
10.12	Offer Letter, by and between American Battery Technology Company and Jesse Deutsch, executed February 13, 2025	x
31.1	Rule 13a-14(a)/ 15d-14(a) Certification of Chief Executive Officer	x
31.2	Rule 13a-14(a)/ 15d-14(a) Certification of Chief Financial Officer	x
32.1	Section 1350 Certification of Chief Executive Officer*
32.2	Section 1350 Certification of Chief Financial Officer*
101	INS Inline XBRL Instant Document.	x
101	SCH Inline XBRL Taxonomy Extension Schema Document	x
101	CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document	x
101	LAB Inline XRBL Taxonomy Label Linkbase Document	x
101	PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document	x
101	DEF Inline XBRL Taxonomy Extension Definition Linkbase Document	x
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)	x

*Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

AMERICAN BATTERY TECHNOLOGY COMPANY

(Registrant)

Date: February 14, 2025	By:	/s/ Ryan Melsert
		Ryan Melsert
		Chief Executive Officer (Principal Executive Officer)

Date: February 14, 2025	By:	/s/ Paul E. McGarry
		Paul E. McGarry
		Interim Chief Financial Officer (Principal Accounting Officer)

Exhibit 10.7

Exhibit 10.11

Exhibit 10.12

February 13, 2025

Jesse Deutsch

Via E-Mail: jessedeutsch@comcast.net

Dear Mr. Deutsch,

On behalf of American Battery Technology Company (the “Company”), I am pleased to outline in this letter (the “Offer Letter” or “Agreement”) the terms and conditions on which we are extending your position of Interim Chief Financial Officer of the Company. This Offer Letter will not constitute an agreement until it has been fully executed by both parties.

1. Position and Duties.

1.1 Position. Subject to the terms and conditions hereof, this contract becomes effective as of February 21, 2025 (the “Employment Date”).

1.2 Responsibilities. As an officer of the Company, you will report to the Company’s Chief Executive Officer (“CEO”) and have such duties and responsibilities as may be assigned to you from time to time.

1.3 Exclusive Services. During your employment by the Company, you shall not, without the express prior written consent of the Company, engage directly or indirectly in any activity that relates to any line of business in which the Company or any of its Affiliates. For the purposes of clarity, nothing in this Agreement shall prevent you from owning, in the aggregate, five percent (5%) or less of the outstanding equity interests of a company whose securities are traded on a national security exchange or on an over-the-counter market.

1.4 No Employment Restriction. You hereby represent and covenant that, except as disclosed to the Company, your employment by the Company does not violate any agreement or covenant to which you are subject or by which you are bound and that there is no such agreement or covenant that could restrict or impair your ability to perform your duties or discharge your responsibilities to the Company.

2. Compensation.

2.1 Base Salary. Your annual base salary is $280,000 and paid according to the Company’s regular payroll practice throughout the calendar year, pro-rated for any partial periods based on the actual number of days in the applicable period. You are also entitled to a one-time signing bonus of $25,000, payable within 14 days of your Employment Date.

3. Benefits.

3.1 Benefit Program. Effective as of the Employment Date, you will be eligible to participate in the Company’s benefit programs available to other employees of the Company at your level.

3.2 Unlimited Time-Off Policy. The system is known as “unlimited time-off policy” or “unlimited paid time off.” It is a vacation policy that allows employees to take as much free time as they feel they need as long as it does not interfere with their work responsibilities, work completion, and the quality of their work. The system is designed to provide the employee flexibility as a reward for making productive use of work hours. The employee is paid for the time they take off from their job. The employee cannot take off more than fourteen consecutive calendar days. Paid time off (“PTO”) is not counted or allocated, and is not accrued, and the employee takes off as much time as needed for vacation, family issues, sick days, etc. Should the employee’s time off impact their productivity, the employee’s time off will be more closely monitored and compared to the job responsibilities of that employee. Unlimited paid time off is a reward for job excellence, not an entitlement.

3.3 Reimbursement. You will be reimbursed for out-of-pocket expenses reasonably incurred in connection with the performance of your duties in accordance with the Company’s policies as established from time to time.

3.4 No Other Benefits. You will not be entitled to any benefit or perquisite other than as specifically set out in this Offer Letter or separately agreed to in writing by the Company.

4. Termination; Payments and Entitlements upon Termination

4.1 Employment Term. The employment term and your employment hereunder may be terminated by either the Company or by you at any time and for any reason, provided that the party terminating your employment hereunder required to give the other party at least thirty (30) days’ advance written notice.

4.2 Termination Due to Death or Disability. In the event your employment is terminated by death or Disability, you or your dependents will be entitled to accrued but unpaid salary owed to you through the date of termination and reimbursement for any legitimate business expenses. Further, the Company will pay for twelve (12) months of COBRA coverage for you (if termination is due to your Disability) or your dependents (if termination is due to your death). “Disability” shall mean an event which results in the Participant being (i) unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, or (ii), by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a period of not less than three months under an accident and health plan covering employees of the Company or its subsidiaries.

4.3 Resignation. If you are a director or officer of the Company, or a director or an officer of a company affiliated or related to the Company at the time of your termination, you will be deemed to have resigned all such positions on the date of your termination, and you agree that upon termination you will execute such tenders of resignation as may be requested by the Company to evidence such resignations.

4.4 Cooperation. From and after termination, you agree, upon the Company’s request, to cooperate in any investigation, litigation, arbitration, or regulatory proceeding regarding events that occurred during the time of your employment by the Company or its Affiliates. You will make yourself available to consult with Company’s counsel, to provide information, to appear for testimony and take such other measures as the Company may reasonably request in respect of your cooperation. The Company will, to the extent permitted by law, reimburse you for any reasonable out-of-pocket expenses that you incur in extending such cooperation, so long as you provide the Company with advance written notice of your request for reimbursement and provide satisfactory documentation of such expenses.

5. Restrictive Covenants.

5.1 Confidentiality.

(a) You acknowledge that in the course of carrying out, performing, and fulfilling your obligations to the Company hereunder, you will have access to and will be entrusted with information that would reasonably be considered confidential to the Company or its Affiliates, the disclosure of which to competitors of the Company, its Affiliates, or to the general public, will be highly detrimental to the best interests of the Company or its Affiliates. Such information includes, without limitation, trade secrets, know-how, marketing plans and techniques, cost figures, client lists, software, and information relating to employees, suppliers, customers and persons in contractual relationship with the Company, technical information, lists of asset sources, the processes and practices of the Company, all information contained in electronic or computer files, all financial information, salary and wage information (except for your own), and any other information that is designated by the Company or its Affiliates as confidential or that you know is confidential, information provided by third parties that the Company or its Affiliates are obligated to keep confidential, and all other proprietary information of the Company or its Affiliates (“Confidential Information”). Except as may be required in the course of carrying out your duties hereunder, you covenant and agree that you will not disclose, for the duration of your employment or at any time thereafter, any such information to any person, other than to the directors, officers, employees or agents of the Company that have a need to know such information, nor shall you use or exploit, directly or indirectly, such information for any purpose other than for the purposes of the Company, nor will you disclose or use for any purpose, other than for those of the Company or its Affiliates, any other information which you may acquire during your employment with respect to the business and affairs of the Company or its Affiliates. You further covenant and agree for the duration of your employment and at any time thereafter to exercise the highest degree of care in safeguarding confidential information against loss, theft, or other inadvertent disclosure and agree generally to take all steps necessary or requested by the Company to ensure maintenance of the confidentiality of the confidential information. Notwithstanding all the foregoing, you shall be entitled to disclose such information if required pursuant to a subpoena or order issued by a court, arbitrator, or governmental body, agency or official, provided you shall first have:

(i) notified the Company;

(ii) consulted with the Company on whether there is an obligation or defense to providing some or all the requested information; and

(iii) if the disclosure is required or deemed advisable, cooperate with the Company to obtain an order or other assurance that such information will be accorded confidential treatment.

Your obligations under this Offer Letter with regard to any particular Confidential Information shall commence immediately upon your first having access to such Confidential Information (whether before or after you begin employment with the Company) and shall continue during and after your employment by the Company until such time as such Confidential Information has become public knowledge other than as a result of your breach of this Offer Letter or breach by those acting in concert with the you or on your behalf.

(b) Notwithstanding the foregoing, you may disclose information relating to your own compensation and benefits to your spouse, attorneys, financial advisors, and taxing authorities. Please note that pursuant to rules promulgated by the U.S. Securities and Exchange Commission under the Securities Exchange Act of 1934 in effect as of the date hereof, the amount and components of your compensation may be required to be publicly disclosed on an annual basis.

(c) Nothing herein prohibits or restricts you (or your attorney) from initiating communications directly with, responding to any inquiry from, or providing testimony before the Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), any other self-regulatory organization, or any other federal or state regulatory authority regarding a securities law violation.

5.2 Intellectual Property. You acknowledge and agree that all right, title, and interest in and to any information, trade secrets, advances, discoveries, improvements, formulae, techniques, processes, research materials, databases, and know-how, whether or not patentable, and whether or not reduced to practice, that are made, conceived, or developed by you, either alone or jointly with others, if on the Company’s time, using Company’s facilities, or relating to the business or affairs of the Company, shall belong exclusively to the Company. You agree that the Company shall be the sole owner of all domestic and foreign patents or other rights pertaining thereto, and further agree to execute all documents that the Company reasonably determines to be necessary or convenient for use in applying for, prosecuting, perfecting, or enforcing patents or other intellectual property rights, including the execution of any assignments, patent applications, or other documents that the Company may reasonably request. Additionally, you agree that all original works of authorship not otherwise within the scope of the preceding sentence that are conceived or developed during your engagement with the Company, either alone or jointly with others, if on the Company’s time, using Company’s facilities, or relating to the Company shall be owned exclusively by the Company. You agree that the Company shall be the sole owner of all rights pertaining thereto, and further agree to execute all documents that the Company determines to be necessary or convenient for establishing in the Company’s name the copyright to any such original works of authorship. In connection with the foregoing, you agree to execute any assignments and/or acknowledgements as may be requested by the Company from time to time. You agree not to claim an interest in any inventions, copyrighted material, patents, or patent applications unless you demonstrate that any such invention, copyrighted material, patent, or patent application was developed before you began providing any services for the Company. This provision is intended to apply only to the extent permitted by applicable law.

5.3 Corporate Opportunities. Any business opportunities related to the business of the Company which become known to you during your employment with the Company must be fully disclosed and made available to the Company by you, and you agree not to take or attempt to take any action if the result would be to divert from the Company any opportunity which is within the scope of its existing or future business.

5.4 Material Non-Public Information. You acknowledge that information about the Company received by you during the term of your employment may constitute material, non-public information and you are aware of the restrictions imposed by the United States securities laws on (a) the purchase or sale of securities by any person who is aware of material, non-public information and (b) on the communication of such information to any other person who may purchase or sell such securities on the basis of such information (including those persons who may be permitted to receive such information). You agree that you will comply with all applicable federal and state securities laws in connection with the purchase or sale, directly or indirectly, of securities of the Company or any other company for which you receive confidential information in connection with your employment. You further agree to comply in all respects with the Company’s Insider Trading Policy and Insider Reporting Procedures with respect to any securities of the Company that you may acquire, and you will comply with all other Company’s policies that may be applicable to you from time to time.

5.5 Non-Disparagement. You will not disparage the Company or any of its Affiliates, directors, officers, employees or other representatives in any manner and you will in all respects avoid any negative criticism of the Company. This Section 5.5 does not, in any way, restrict or impede you from exercising protected rights to the extent that such rights cannot be waived by agreement or from complying with any applicable law or regulation or a valid order of a court of competent jurisdiction or an authorized government agency, provided that such compliance does not exceed that required by the law, regulation, or order. The Company agrees and covenants that it shall direct its officers and directors to refrain from making any defamatory or disparaging remarks, comments, or statements concerning you to any third parties.

5.6 Injunctive Relief. You acknowledge and agree that in the event of a breach of the covenants, provisions, and restrictions in this Section 5, the Company’s remedy in the form of monetary damages will be inadequate and that the Company shall be, and is hereby, authorized and entitled, in addition to all other rights and remedies available, to apply for and obtain from a court of competent jurisdiction interim and permanent injunctive relief and an accounting of all profits and benefits arising out of such breach. You acknowledge that the restrictions in this Section 5 are reasonable, and you acknowledge that the operation of restrictions contained in this Section 5 may seriously constrain your freedom to seek other remunerative employment. If any of the restrictions are determined to be unenforceable as going beyond what is reasonable in the circumstances for the protection of the interests of the Company but would be valid, for example, if the scope of their time periods or geographic areas were limited, you consent to the court making such modifications as may be required and such restrictions shall apply with such modifications as may be necessary to make them valid and effective.

5.7 Survival of Restrictions. Each provision of this Section 5 shall survive the termination of this Offer Letter or the termination of your employment (regardless of the reason for such termination).

6. General Provisions.

6.1 Entire Agreement. This Offer Letter, together with the plans and documents referred to herein, constitutes and expresses the whole agreement of the parties hereto with reference to any of the matters or things herein provided for or herein before discussed or mentioned with reference to your employment. All promises, representations, collateral agreements, and undertakings not expressly incorporated in this Offer Letter are hereby superseded by this Offer Letter.

6.2 Amendment. This Offer Letter may be amended or modified only by a writing signed by both of the parties hereto.

6.3 Assignment. This Offer Letter may be assigned by the Company to any successor to its business or operations. Your rights hereunder may not be transferred by you except by will or by the laws of descent and distribution and except as far as applicable law may otherwise require. Any assignment in violation of the preceding sentence shall be void.

6.4 Governing Law; Consent to Personal Jurisdiction, Venue and Arbitration. This Offer Letter takes effect upon its acceptance by you and execution by the Company. The validity, interpretation, and performance of this Offer Letter shall be governed, interpreted, and construed in accordance with the laws of the State of Nevada without giving effect to the principles of comity or conflicts of laws thereof. You hereby consent to personal jurisdiction and venue, for any action brought by the Company arising out of a breach or threatened breach of this Offer Letter, or out of the relationship established by this Offer Letter, exclusively in the United States District Court for the District of Nevada, Reno Division, or in the Second Judicial District, Washoe County, Nevada. Except for disputes, controversies, or claims or other actions seeking injunctive or equitable relief, which may be brought before any court having jurisdiction, any controversy, dispute, or claim (“Claim”) whatsoever between you on the one hand, and the Company, or any of its Affiliates or any employees, officers, directors, agents, and representatives of the Company or its Affiliates on the other hand, shall be settled by binding arbitration, at the request of either party, under the Employment Arbitration Rules and Mediation Procedures of the American Arbitration Association. The arbitrator shall apply Nevada law. The demand for arbitration must be in writing and made within the applicable statute of limitations period. The arbitration shall take place in Reno, Nevada, or in another location mutually agreed to by the parties. The parties shall be entitled to conduct reasonable discovery, including conducting depositions and requesting documents. The arbitrator shall have the authority to resolve discovery disputes, including but not limited to determining what constitutes reasonable discovery. The arbitrator shall prepare in writing and timely provide to the parties a decision and award which includes factual findings and the reasons upon which the decision is based. The decision of the arbitrator shall be binding and conclusive on the parties, except as may otherwise be required by law. Judgment upon the award rendered by the arbitrator may be entered in any court having proper jurisdiction. Each party shall bear its or his own fees and costs incurred in connection with the arbitration, except that the arbitrator may award attorneys’ fees and costs in accordance with applicable law.

You understand and agree that by using arbitration to resolve any Claims between you and the Company (or its Affiliates) you are giving up any right that you may have to a judge or jury trial regarding those Claims.

6.5 Severability. The invalidity of any one or more of the words, phrases, sentences, clauses, or sections contained in this Offer Letter shall not affect the enforceability of the remaining portions of the Offer Letter or any part thereof, all of which are inserted conditionally on their being valid in law, and, in the event that any one or more of the words, phrases, sentences, clauses, or sections contained in the Offer Letter shall be declared invalid, the Offer Letter shall be construed as if such invalid word or words, phrase or phrases, sentence or sentences, clause or clauses, or section or sections had not been inserted.

6.6 Section Headings and Gender. The section headings herein are for reference purposes only and shall not affect in any way the meaning or interpretation of this Offer Letter.

6.7 No Term of Employment. Nothing herein obligates the Company to continue to employ you. Where lawfully permitted in any jurisdiction in which you perform employment responsibilities on behalf of the Company, your employment shall be at will.

6.8 Indemnification. The Company will indemnify and hold you harmless to the maximum extent permitted by applicable law against judgments, fines, amounts paid in settlement and reasonable expenses, including reasonable attorneys’ fees, in connection with the defense of, or as a result of any action, suit, or proceeding, whether civil, criminal, administrative, or investigative (a “Proceeding”) (or any appeal from any such Proceeding), other than any Proceeding initiated by you or the Company related to any contest or dispute between you and the Company with respect to this Offer Letter or your employment hereunder, in which you are made or are threatened to be made a party by reason of the fact that you are or were an director, officer, member, employee, or agent of the Company or any Affiliate. In addition, the Company agrees that you shall be covered and insured up to the maximum limits provided by any insurance which the Company maintains to indemnify its directors and officers (as well as any insurance that it maintains to indemnify the Company for any obligations which it incurs because of its undertaking to indemnify its officers and directors). Costs and expenses incurred by you in defense of a Proceeding (including attorneys’ fees) shall be paid by the Company in advance of the final disposition of such litigation upon receipt by the Company of: (i) a written request for payment; (ii) appropriate documentation evidencing the incurrence, amount, and nature of the costs and expenses for which payment is being sought; and (iii) an undertaking adequate under applicable law made by or on your behalf to repay the amounts so paid if it shall ultimately be determined that the you are not entitled to be indemnified by the Company under this Offer Letter.

6.9 Survivorship. Upon the termination of your employment, the respective rights and obligations of the parties shall survive such termination to the extent necessary to carry out the intended preservation of such rights and obligations.

6.10 Taxes. All payments under this Offer Letter shall be subject to withholding of such amounts, if any, relating to tax or other payroll deductions as the Company may determine and should withhold pursuant to any applicable law or regulation.

6.11 Set-Off. The Company may set off any amount or obligation which may be owed by you to the Company against any amount or obligation owed by the Company to you.

6.12 Records. All books, records, and accounts relating in any manner to the Company or to any suppliers, customers, or clients of the Company, whether prepared by you or otherwise coming into your possession, shall be the exclusive property of the Company and immediately returned to the Company upon termination of employment or upon request at any time.

6.13 Return of Company Property. You agree not to remove (either physically or electronically) any property belonging to the Company from the Company’s premises, except as required in the ordinary course of your employment, unless the Company grants you express written authorization to do so. Upon the termination of your employment, and earlier if the Company requests at any time, you shall deliver to the Company (and shall not keep copies in your possession or deliver to any other person or entity) all of the Company’s property in your possession. This requirement to return the Company’s property shall also be a condition of the Company’s right to keep an amount of money or benefit paid to you upon your termination, if any. Further, the Company has the right to pursue all legal remedies to: (i) achieve the return of Company property; (ii) recoup any money, or value of any benefit, paid to you upon your termination; and (iii) obtain reasonable attorneys’ fees, costs, or disbarments incurred in the exercise of its legal rights under this Section.

6.14 Counterparts. This Offer Letter may be executed in counterparts, each of which shall be deemed to be an original but all of which together shall constitute the same instrument.

6.15 Consultation with Counsel. You acknowledge that you have conferred with your own legal counsel with respect to this Offer Letter, and that you understand the restrictions and limitations that it imposes upon your conduct.

Please indicate your acceptance of this offer by returning one signed original of this Offer Letter.

Yours truly,

/s/ Ryan Melsert		February 13, 2025
Ryan Melsert		Date
CEO
American Battery Technology Company

I accept this offer of employment and agree to be bound by the terms and conditions listed herein.

/s/ Jesse Deutsch		February 13, 2025
Jesse Deutsch, Interim CFO		Date
American Battery Technology Company

EXHIBIT 31.1

The certification required by Rule 13a–14(a) (17 CFR 240.13a–14(a)) or Rule 15d–14(a) (17CFR 240. 15d–14(a))

I, Ryan Melsert, certify that:

1.	I have reviewed this Form 10–Q of American Battery Technology Company (the “Registrant”);

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.	The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act 13a–15(e) and 15d – 15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financing reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

5.	The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: February 14, 2025	By:	/s/ Ryan Melsert
		Ryan Melsert
		Chief Executive Officer (Principal Executive Officer)

EXHIBIT 31.2

The certification required by Rule 13a–14(a) (17 CFR 240.13a–14(a)) or Rule 15d–14(a) (17CFR 240. 15d–14(a))

I, Paul E. McGarry, certify that:

1.	I have reviewed this Form 10–Q of American Battery Technology Company (the “Registrant”);

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.	The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act 13a–15(e) and 15d – 15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f) for the Registrant and have:

5.	The Registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

Date: February 14, 2025	By:	/s/ Paul E. McGarry
		Paul E. McGarry
		Interim Chief Financial Officer (Principal Accounting Officer)

EXHIBIT 32.1

CERTIFICATE PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES–OXLEY ACT OF 2002

In connection with the Quarterly Report (the “Report”) on Form 10–Q of American Battery Technology Company. (the “Company”) for the period ended December 31, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, Ryan Melsert, Chief Executive Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes–Oxley Act of 2002, that, to the best of my knowledge and belief:

1.	The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934, as amended; and

2.	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 14, 2025	By:	/s/ Ryan Melsert
		Ryan Melsert
		Chief Executive Officer (Principal Executive Officer)

EXHIBIT 32.2

CERTIFICATE PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES–OXLEY ACT OF 2002

In connection with the Quarterly Report (the “Report”) on Form 10–Q of American Battery Technology Company. (the “Company”) for the period ended December 31, 2024, as filed with the Securities and Exchange Commission on the date hereof, I, Paul E. McGarry, Interim Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes–Oxley Act of 2002, that, to the best of my knowledge and belief:

1.	The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934, as amended; and

2.	The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 14, 2025	By:	/s/ Paul E. McGarry
		Paul E. McGarry
		Interim Chief Financial Officer (Principal Accounting Officer)

Cover - shares	6 Months Ended
Cover - shares	Dec. 31, 2024	Feb. 10, 2025
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2024
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2025
Current Fiscal Year End Date	--06-30
Entity File Number	000-41811
Entity Registrant Name	AMERICAN BATTERY TECHNOLOGY COMPANY
Entity Central Index Key	0001576873
Entity Tax Identification Number	33-1227980
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	100 Washington Street
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Reno
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89503
City Area Code	(775)
Local Phone Number	473-4744
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	ABAT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		84,658,010

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
ASSETS
Cash	$ 15,623,762	$ 7,001,786
Accounts receivable	323,975	228,499
Inventory (Note 4)	574,103	154,320
Grants receivable (Note 5)	27,119	191,522
Prepaid expenses and deposits	527,230	1,813,050
Subscription receivable (Note 13)		608,333
Restricted cash	5,000,000
Assets held-for-sale (Note 7)	8,408,538	8,408,538
Total current assets	30,484,727	18,406,048
Property, plant and equipment, net (Note 7)	44,534,680	46,314,966
Mining properties (Note 8)	8,392,977	8,392,977
Intangible assets (Note 9)	4,519,038	4,519,038
Right-of-use asset (Note 12)	357,431	42,103
Total assets	88,288,853	77,675,132
LIABILITIES & STOCKHOLDERS’ EQUITY
Accounts payable and accrued liabilities (Note 10)	7,167,414	9,233,806
Right-of-use lease liability – operating	108,600	117,131
Notes payable, current (Note 11)	10,165,377	6,447,361
Total current liabilities	17,441,391	15,798,298
Right-of-use lease liability – operating – long-term	250,416
Equity compensation liability (Note 15)		409,194
Total liabilities	17,691,807	16,207,492
Commitments and contingencies (Note 17)
Stockholders’ Equity:
Common Stock Authorized: 250,000,000 common shares, par value of $0.001 per share; Issued and outstanding: 84,392,375 and 64,061,763 common shares as of December 31, 2024, and June 30, 2024, respectively	84,390	64,059
Additional paid-in capital	310,351,869	275,589,383
Common stock issuable	(1,415,806)	(857,470)
Accumulated deficit	(238,423,407)	(213,328,332)
Total stockholders’ equity	70,597,046	61,467,640
Total liabilities and stockholders’ equity	88,288,853	77,675,132
Series A Preferred Stock [Member]
Stockholders’ Equity:
Preferred stock value
Series B Preferred Stock [Member]
Stockholders’ Equity:
Preferred stock value
Series C Preferred Stock [Member]
Stockholders’ Equity:
Preferred stock value
Series D Preferred Stock [Member]
Stockholders’ Equity:
Preferred stock value

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Dec. 31, 2024	Jun. 30, 2024
Common stock, shares authorized	250,000,000	250,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	84,392,375	64,061,763
Common stock, shares outstanding	84,392,375	64,061,763
Series A Preferred Stock [Member]
Preferred stock, shares authorized	33,334	33,334
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued
Preferred stock, shares outstanding
Series B Preferred Stock [Member]
Preferred stock, shares authorized	133,334	133,334
Preferred stock, par value	$ 10.00	$ 10.00
Preferred stock, shares issued
Preferred stock, shares outstanding
Series C Preferred Stock [Member]
Preferred stock, shares authorized	66,667	66,667
Preferred stock, par value	$ 10.00	$ 10.00
Preferred stock, shares issued
Preferred stock, shares outstanding
Series D Preferred Stock [Member]
Preferred stock, shares authorized		5
Preferred stock, par value		$ 0.001
Preferred stock, shares issued	5
Preferred stock, shares outstanding	5

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Revenue	$ 332,440		$ 534,400
Cost of goods sold	3,305,743		5,848,384
Gross loss	(2,973,303)		(5,313,984)
Expenses:
General and administrative	7,673,022	4,416,716	12,682,863	7,470,713
Research and development	2,919,865	3,569,167	4,952,000	7,183,018
Exploration costs	234,568	823,425	655,075	2,173,345
Total operating expenses	10,827,455	8,809,308	18,289,938	16,827,076
Net loss before other income (expense)	(13,800,758)	(8,809,308)	(23,603,922)	(16,827,076)
Other income (expense)
Interest income (expense)	597	(7,647)	(3,978)	(142,636)
Amortization and accretion of financing costs	(732,197)	(1,132,258)	(1,904,546)	(1,865,154)
Unrealized gain (loss) on investment		826		(5,497)
Change in fair value of derivative liability		(229,472)	705,184	(229,473)
Loss on debt extinguishment			(675,648)
Loss on private placement			(567,161)
Change in fair value of liability-classified financial instruments	1,116,388		875,100
Other income	15,464		79,896
Total other income (expense)	400,252	(1,368,551)	(1,491,153)	(2,242,760)
Net loss	$ (13,400,506)	$ (10,177,859)	$ (25,095,075)	$ (19,069,836)
Net loss per share, basic	$ (0.18)	$ (0.21)	$ (0.35)	$ (0.40)
Net loss per share, diluted	$ (0.18)	$ (0.21)	$ (0.35)	$ (0.40)
Weighted average shares outstanding, basic	75,315,210	47,760,809	72,123,576	47,357,879
Weighted average shares outstanding, diluted	75,315,210	47,760,809	72,123,576	47,357,879

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Common Stock Issuable [Member]	Retained Earnings [Member]	Total
Balance at Jun. 30, 2023		$ 45,887	$ 223,134,798	$ (1,484,693)	$ (160,826,508)	$ 60,869,484
Balance, shares at Jun. 30, 2023		45,888,131
Shares issued upon vesting of share-based awards		$ 135	(135)
Shares issued upon vesting of share-based awards, shares		132,142
Stock-based compensation expense			3,369,269			3,369,269
Shares issued pursuant to share purchase agreement, net of issuance costs		306	3,009,694			3,010,000
Net loss for the period					(8,891,978)	(8,891,978)
Shares issued for professional services		$ 1	$ 15,174	$ (15,307)		$ (132)
Shares issued for professional services, shares		1,326
Shares issued pursuant to rounding of reverse stock split		59	(59)
Shares issued pursuant to rounding of reverse stock split, shares		59,164
Shares reclaimed pursuant to asset acquisition		$ (128)	$ (1,255,650)	$ 1,500,000		$ 244,222
Shares reclaimed pursuant to asset acquisition, shares		(128,206)
Shares issued pursuant to share purchase agreement, net of issuance costs, shares		306,252
Shares issued pursuant to warrant exercises		$ 46	(46)	37,500		37,500
Shares issued pursuant to warrant exercises, shares		45,545
Balance at Sep. 30, 2023		$ 46,306	228,273,045	37,500	(169,718,486)	58,638,365
Balance, shares at Sep. 30, 2023		46,304,354
Balance at Jun. 30, 2023		$ 45,887	223,134,798	(1,484,693)	(160,826,508)	60,869,484
Balance, shares at Jun. 30, 2023		45,888,131
Stock-based compensation expense			7,630,596
Net loss for the period						(19,069,836)
Balance at Dec. 31, 2023		$ 49,345	245,401,556		(179,896,345)	65,554,556
Balance, shares at Dec. 31, 2023		49,343,225
Balance at Sep. 30, 2023		$ 46,306	228,273,045	37,500	(169,718,486)	58,638,365
Balance, shares at Sep. 30, 2023		46,304,354
Shares issued upon vesting of share-based awards		$ 181	(181)
Shares issued upon vesting of share-based awards, shares		180,811
Stock-based compensation expense			4,261,327			4,261,327
Shares issued pursuant to share purchase agreement, net of issuance costs		$ 2,800	12,829,925			12,832,725
Shares issued pursuant to share purchase agreement, net of issuance costs, shares		2,799,973
Net loss for the period					(10,177,859)	(10,177,859)
Shares issued pursuant to warrant exercises		58	37,440	(37,500)		(2)
Balance at Dec. 31, 2023		$ 49,345	245,401,556		(179,896,345)	65,554,556
Balance, shares at Dec. 31, 2023		49,343,225
Balance at Jun. 30, 2024		$ 64,059	275,589,383	(857,470)	(213,328,332)	61,467,640
Balance, shares at Jun. 30, 2024		64,061,763
Shares issued upon vesting of share-based awards		$ 353	(353)
Shares issued upon vesting of share-based awards, shares		353,221
Stock-based compensation expense			2,420,747			2,420,747
Shares issued pursuant to share purchase agreement, net of issuance costs		$ 5,939	6,218,486	102,743		6,327,168
Shares issued pursuant to share purchase agreement, net of issuance costs, shares		5,938,786
Settlement of receivable pursuant to share purchase agreement		$ 488	607,848	(608,336)
Settlement of receivable pursuant to share purchase agreement, shares		487,838
Reclassification of equity-linked contracts to liabilities			(502,627)			(502,627)
Repurchase of Series D Redeemable Preferred shares	$ 100					100
Issuance of common shares under the Employee Stock Purchase Plan, shares	5
Issuance of common shares and warrants pursuant to subscription agreements		$ 1,774	533,623			535,397
Issuance of common shares and warrants pursuant to subscription agreements, shares		1,774,213
Shares issued pursuant to debt extinguishment		$ 726	740,014			740,740
Shares issued pursuant to debt extinguishment, shares		726,216
Shares issued pursuant to share purchase agreement, net of issuance costs				50,000		50,000
Net loss for the period					(11,694,569)	(11,694,569)
Reclassification of equity-classified awards from equity compensation liability			502,627			502,627
Balance at Sep. 30, 2024	$ 100	$ 73,339	285,607,121	(1,313,063)	(225,022,901)	59,344,596
Balance, shares at Sep. 30, 2024	5	73,342,037
Balance at Jun. 30, 2024		$ 64,059	275,589,383	(857,470)	(213,328,332)	61,467,640
Balance, shares at Jun. 30, 2024		64,061,763
Net loss for the period						(25,095,075)
Balance at Dec. 31, 2024		$ 84,390	310,351,869	(1,415,806)	(238,423,407)	70,597,046
Balance, shares at Dec. 31, 2024		84,392,375
Balance at Sep. 30, 2024	$ 100	$ 73,339	285,607,121	(1,313,063)	(225,022,901)	59,344,596
Balance, shares at Sep. 30, 2024	5	73,342,037
Shares issued upon vesting of share-based awards		$ 1,074	(1,074)
Shares issued upon vesting of share-based awards, shares		1,073,399
Stock-based compensation expense			6,330,914			6,330,914
Shares issued pursuant to share purchase agreement, net of issuance costs		$ 690	695,774	(102,743)		593,721
Shares issued pursuant to share purchase agreement, net of issuance costs, shares		690,553
Reclassification of equity-linked contracts to liabilities			(467,191)			(467,191)
Repurchase of Series D Redeemable Preferred shares	$ (100)					(100)
Issuance of common shares under the Employee Stock Purchase Plan, shares	(5)	177,440
Net loss for the period					(13,400,506)	(13,400,506)
Issuance of common shares under the Employee Stock Purchase Plan		178	140,568			140,746
Issuance of common shares under the Employee Stock Purchase Plan, shares
Reclassification of equity-classified awards from equity compensation liability			467,191			467,191
Reclassification of derivative equity instruments from long-term liabilities			2,066,569			2,066,569
Rescission of common shares and warrants pursuant to subscription agreements		$ (875)				(875)
Rescission of Number common shares and warrants pursuant to subscription agreements, shares		(875,000)
Shares issued pursuant to troubled debt restructuring		$ 1,210	1,142,580			1,143,790
Shares issued pursuant to troubled debt restructuring, shares		1,210,360
Issuance of common shares and warrants pursuant to registered direct offerings		$ 8,774	13,902,226			13,911,000
Issuance of number of shares pursuant to registered direct offerings, shares		8,773,586
Shares issued pursuant to warrant exercises, shares		58,087
Balance at Dec. 31, 2024		$ 84,390	$ 310,351,869	$ (1,415,806)	$ (238,423,407)	$ 70,597,046
Balance, shares at Dec. 31, 2024		84,392,375

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash Flows From Operating Activities:
Net loss	$ (25,095,075)	$ (19,069,836)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	2,518,001	81,410
Accretion of financing costs	1,904,546	1,865,154
Amortization of right-of-use asset	52,315	50,525
Write-down of inventory to net realizable value	2,394,274
Unrealized loss on investment		5,497
Stock-based compensation	9,502,030	7,691,511
Shares issued for professional services		(448)
Change in fair value of derivative liability	(705,184)	229,473
Change in fair value of conversion option	(138,060)
Change in fair value of liability-classified equity-linked contracts	(737,040)
Loss on extinguishment of debt	675,648
Loss on private placement	567,161
Changes in operating assets and liabilities:
Accounts receivable	(95,476)
Inventory	(2,814,057)	(489,238)
Grants receivable	164,403	(326,170)
Prepaid expenses and deposits	1,285,820	416,234
Other current assets		(316,351)
Accounts payable and accrued liabilities	(2,053,400)	2,502,865
Right-of-use lease liabilities	(241,884)	(59,326)
Net Cash Used in Operating Activities	(12,815,978)	(7,418,700)
Cash Flows From Investing Activities:
Other acquisition deposits		(279,878)
Acquisition of property, plant and equipment, and water rights	(1,509,581)	(10,418,868)
Purchase of water rights/intangible assets		(169,714)
Net Cash Used in Investing Activities	(1,509,581)	(10,868,460)
Cash Flows From Financing Activities:
Proceeds from exercise of share purchase warrants		37,499
Proceeds from employee stock purchase plan	140,746
Proceeds from issuance of common shares through At-The-Market offering	7,579,122
Proceeds from subscription agreements (Note 13)	1,900,000
Proceeds from registered direct offerings	15,000,000
Payment of issuance costs, registered direct offerings	(1,089,000)
Proceeds from notes payable, net of issuance costs	9,900,000	20,287,118
Principal paid on notes payable	(5,483,333)	(11,400,000)
Proceeds from share purchase agreement, net of issuance costs		14,689,178
Net Cash Provided by Financing Activities	27,947,535	23,613,795
Increase in Cash and Restricted Cash	13,621,976	5,326,635
Cash and Restricted Cash – Beginning of Period	7,001,786	2,320,149
Cash and Restricted Cash – End of Period	$ 20,623,762	$ 7,646,784

Pay vs Performance Disclosure - USD ($)	3 Months Ended				6 Months Ended
Pay vs Performance Disclosure - USD ($)	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2024	Dec. 31, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ (13,400,506)	$ (11,694,569)	$ (10,177,859)	$ (8,891,978)	$ (25,095,075)	$ (19,069,836)

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 31, 2024
Insider Trading Arrangements [Line Items]
Name	Jesse Deutsch
Title	Chief Financial Officer

Organization and Nature of Operations

6 Months Ended

Dec. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Nature of Operations

1. Organization and Nature of Operations

Liquidity and Going Concern

6 Months Ended

Dec. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Liquidity and Going Concern

2. Liquidity and Going Concern

Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements

6 Months Ended

Dec. 31, 2024

Accounting Policies [Abstract]

Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements

3. Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

	As Reported			Adjustments			As Corrected
	Three months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Operating expenses
General and administrative	$	4,310,452		$	106,264		$	4,416,716
Research and development		3,148,873			420,294			3,569,167
Exploration		771,523			51,902			823,425
Total operating expenses		8,230,848			578,460			8,809,308

Net loss before other income (expense)	$	(8,230,848	)	$	(578,460	)	$	(8,809,308	)

Other income (expense)
Amortization and accretion of financing costs	$	(1,053,766	)	$	(78,492	)	$	(1,132,258	)
Change in fair value of derivative liability		-			(229,472	)		(229,472	)
Total other income (expense)		(1,060,587	)		(307,965	)		(1,368,551	)

Net loss attributable to common stockholders	$	(9,291,435	)	$	(886,424	)	$	(10,177,859	)
Net loss per share, basic and diluted	$	(0.19	)	$	(0.02	)	$	(0.21	)

	As Reported			Adjustments			As Corrected
	Six months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Operating expenses
General and administrative	$	7,259,298		$	211,415		$	7,470,713
Research and development		5,304,187			1,878,831			7,183,018
Exploration		2,051,305			122,040			2,173,345
Total operating expenses		14,614,790			2,212,286			16,827,076

Net loss before other income (expense)	$	(14,614,790	)	$	(2,212,286	)	$	(16,827,076	)

Other income (expense)
Amortization and accretion of financing costs	$	(1,760,497	)	$	(104,657	)	$	(1,865,154	)
Change in fair value of derivative liability		-			(229,473	)		(229,473	)
Total other income (expense)		(1,908,630	)		(334,130	)		(2,242,760	)

Net loss attributable to common stockholders	$	(16,523,420	)	$	(2,546,416	)	$	(19,069,836	)
Net loss per share, basic and diluted	$	(0.35	)	$	(0.05	)	$	(0.40	)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

	As Reported			Adjustments			As Corrected
	Three months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Stockholders’ Equity

Additional paid-in capital:
Stock-based compensation expense		3,836,466			424,861			4,261,327
Balance, December 31, 2023	$	243,020,935		$	2,380,621		$	245,401,556

Accumulated deficit
Net loss for period		(9,291,435	)		(886,424	)		(10,177,859	)
Balance, December 31, 2023	$	(176,496,995	)	$	(3,399,350	)	$	(179,896,345	)

Total stockholders’ equity
Balance, December 31, 2023	$	66,573,285		$	(1,018,729	)	$	65,554,556

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

	As Reported			Adjustments			As Corrected
	Six months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Stockholders’ Equity

Additional paid-in capital:
Stock-based compensation expense		5,757,908			1,872,688			7,630,596
Balance, December 31, 2023	$	243,020,935		$	2,380,621		$	245,401,556

Accumulated deficit
Net loss for period		(16,523,420	)		(2,546,416	)		(19,069,836	)
Balance, December 31, 2023	$	(176,496,995	)	$	(3,399,350	)	$	(179,896,345	)

Total stockholders’ equity
Balance, December 31, 2023	$	66,573,285		$	(1,018,729	)	$	65,554,556

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

	As Reported			Adjustments			As Corrected
	Six months ended December 31, 2023
	As Reported			Adjustments			As Corrected
Operating Activities
Net loss attributable to stockholders	$	(16,523,420	)	$	(2,546,416	)	$	(19,069,836	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and accretion expense	$	1,760,497		$	104,657		$	1,865,154
Stock-based compensation		5,757,908			1,933,603			7,691,511
Shares issued for professional services		(132	)		(316	)		(448	)
Change in fair value of derivative liability		-			229,473			229,473
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	$	2,164,539		$	279,000		$	2,443,539

Net cash used in operating activities	$	(7,418,700	)	$	-		$	(7,418,700	)

Use of Estimates

Cash and Cash Equivalents

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Fair Value of Financial Instruments

Level 1: Quoted prices (unadjusted) in active markets for identical assets and liabilities that the reporting entity can assess at the measurement date.

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

The Company’s non-recurring fair value measurements include the valuation of the assets held-for-sale as of December 31, 2024. See Note 7 for relevant fair value disclosures.

Adoption of Recent Accounting Pronouncements

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Inventories

6 Months Ended

Dec. 31, 2024

Inventory Disclosure [Abstract]

Inventories

4. Inventories

Schedule of Inventories

	December 31, 2024		June 30, 2024
Raw materials	$	449,665	$	66,088
Finished goods		124,438		88,232
Total	$	574,103	$	154,320

Government Grants and Tax Credit Awards

6 Months Ended

Dec. 31, 2024

Government Grants And Tax Credit Awards

Government Grants and Tax Credit Awards

5. Government Grants and Tax Credit Awards

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Derivative Liabilities

6 Months Ended

Dec. 31, 2024

Derivative Liabilities

Derivative Liabilities

6. Derivative Liabilities

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

The table below sets forth the Black-Scholes inputs and assumptions for the Company’s valuation and re-valuation of its derivative liabilities for the three months ending December 31:

	2024
Weighted average expected term (years)		0.01 – 4.67
Risk-free interest rate		4.26% - 4.69	%
Dividend yield		0	%
Volatility		6.69% - 117.89	%

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

A summary of the activity related to derivative liabilities for the three months ending December 31, 2024, is as follows:

Schedule of Derivative Liabilities

	Warrant Derivative Liabilities			Conversion Option Derivative Liability			Total Derivative Liabilities

Balance, September 30, 2024	$	3,117,647		$	939,435		$	4,057,082
Change in fair value		(639,727	)		(388,365	)		(1,028,092	)
Fair value of extinguishments during the period		(87,421	)		-			(87,421	)
Fair value of reclassifications to accounts payable during the period		(875,000	)		-			(875,000	)
Fair value of reclassifications to equity during the period		(1,515,499	)		(551,070	)		(2,066,569	)
Balance, December 31, 2024	$	-		$	-		$	-

Property, Plant and Equipment

6 Months Ended

Dec. 31, 2024

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment

7. Property, Plant and Equipment

The table below presents the property, plant and equipment as of December 31, 2024 and June 30, 2024:

Schedule of Property and Equipment

	December 31, 2024			June 30, 2024
Land	$	8,860,916		$	8,860,916
Building		16,633,661			24,867,784
Equipment and vehicles		23,232,967			14,313,970
Total property, plant and equipment		48,727,544			48,042,670
Less: accumulated depreciation		(4,192,864	)		(1,727,704	)
Property, plant and equipment, net		44,534,680		$	46,314,966

Mining Properties

6 Months Ended

Dec. 31, 2024

Mining Properties

Mining Properties

8. Mining Properties

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Intangible Assets

6 Months Ended

Dec. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

9. Intangible Assets

The table below presents total intangible assets at:

Schedule of Intangible Assets

		December 31, 2024				June 30, 2024
Water rights		$	4,519,038			$	4,519,038

Accounts Payable and Accrued Liabilities

6 Months Ended

Dec. 31, 2024

Payables and Accruals [Abstract]

Accounts Payable and Accrued Liabilities

10. Accounts Payable and Accrued Liabilities

The table below presents total accounts payable and accrued liabilities at:

	December 31, 2024		June 30, 2024
Trade payables	$	2,038,587	$	4,255,398
Accrued fixed assets		225,104		996,970
Accrued expenses		4,903,723		2,244,265
Market agreement settlement		-		1,800,000
Total accounts payable and accrued liabilities	$	7,167,414	$	9,296,633

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Notes Payable

6 Months Ended

Dec. 31, 2024

Debt Disclosure [Abstract]

Notes Payable

11. Notes Payable

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

The table below presents the net carrying amounts of the 2024 Notes as of:

	December 31, 2024
Principal outstanding	$	12,000,000
Debt discount		(2,243,790	)
Amortization of debt discount		409,167
Net carrying value	$	10,165,377

The table below presents the maturities of notes payable as of December 31, 2024:

Schedule of Maturities of Notes Payable


December 31, 2024	$	12,000,000
Less: unamortized debt discount and issuance costs		(1,834,623	)
Total notes payable	$	10,165,377

Notes payable, current	$	10,165,377
Notes payable, non-current	$	-

Leases

6 Months Ended

Dec. 31, 2024

Leases

Leases

12. Leases

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

	December 31, 2024		June 30, 2024
Operating lease right-of-use asset	$	357,431	$	42,103
Operating lease liabilities	$	359,015	$	54,304

The table below presents the maturities of operating lease liabilities as of December 31, 2024:


December 31, 2025	$	133,413
December 31, 2026		139,011
December 31, 2027		132,130
Total lease payments		404,554
Less: discount		(45,539	)

Total operating lease liabilities	$	359,015

Operating lease liabilities, current	$	108,600
Operating lease liabilities, non-current	$	250,416

Weighted average lease term (years)			2.83
Weighted average discount rate			8.00	%

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Stockholders’ Equity

6 Months Ended

Dec. 31, 2024

Equity [Abstract]

Stockholders’ Equity

13. Stockholders’ Equity

Preferred Stock

Subsequent to the Company’s annual meeting on November 13, 2024, the Company redeemed the Series D Preferred Stock for $100.

Series A Preferred Stock

Series B Preferred Stock

Series C Preferred Stock

Series D Preferred Stock

Common Stock

In November 2024, the Company’s shareholders approved and adopted an amendment to the articles of incorporation to increase the number of authorized shares of the Company’s common stock from 80,000,000 to 250,000,000. As of December 31, 2024, the Company has 250,000,000 shares of common stock authorized, with a par value of $0.001 per share.

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Six months ended December 31, 2024:

During the period, the Company issued 1,426,620 common shares upon vesting of share-based awards.

The Company had the following potentially dilutive shares outstanding as of December 31:

	2024		2023
Convertible notes		13,282,344		1,942,363
Warrants		16,138,037		5,731,666
Share awards outstanding		8,052,791		2,871,252
Total potentially dilutive		37,473,172		10,545,281

Share Purchase Warrants

6 Months Ended

Dec. 31, 2024

Share Purchase Warrants

Share Purchase Warrants

14. Share Purchase Warrants

	Number of Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value

Balance, June 30, 2024		6,928,758		$	12.95
Granted		3,548,426			1.01
Exercised		-			-
Expired		(1,082,715	)		12.02
Balance, September 30, 2024		9,394,469		$	8.55
Granted		8,969,762			1.90
Exercised		-			-
Rescinded		(1,750,000	)		1.00
Expired		(476,194	)		10.50
Balance, December 31, 2024		16,138,037		$	5.61		4.12	$	-
Exercisable, December 31, 2024		15,365,150		$	4.53		4.08	$	-

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

Equity Compensation Awards

6 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Equity Compensation Awards

15. Equity Compensation Awards

The table below reflects the share award activity for the period ended December 31, 2024:

	Units			Weighted- Average Grant Date Fair Value per Unit

Unvested share awards at June 30, 2024		3,428,604		$	5.02
Granted		185,742			1.00
Vested		(410,504	)		4.10
Forfeitures		(26,875	)	$	5.22
Unvested share awards at September 30, 2024		3,176,967		$	4.90
Granted		5,822,024			0.96
Vested		(924,430	)		2.43
Forfeitures		(21,770	)	$	6.76
Unvested awards at December 31, 2024		8,052,791		$	2.33

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

The table below presents the stock-based compensation expense per respective line item on the condensed consolidated statements of operations for the six months ended December 31:

	2024		2023

Cost of goods sold	$	267,449	$	-
General and administrative		6,836,740		4,083,070
Research and development		2,295,427		2,659,061
Exploration		102,417		949,380
Total stock-based compensation	$	9,502,030	$	7,691,511

Supplemental Statement of Cash Flow Disclosures

6 Months Ended

Dec. 31, 2024

Supplemental Cash Flow Elements [Abstract]

Supplemental Statement of Cash Flow Disclosures

16. Supplemental Statement of Cash Flow Disclosures

For the six months ended December 31:

	2024		2023

Supplemental disclosures:

Interest paid	$	4,575	$	14,462

Non-cash investing and financing activities:

Purchases of property and equipment accrued in current liabilities		225,104		-
Deposits capitalized as investing activities		-		27,103,351
Right-of-use asset obtained in exchange for lease liability		367,643		-
Debt payment satisfied with common shares		1,742,580		-
Payable recognized upon rescission of subscription agreement		875,000		-

Commitments and Contingencies

6 Months Ended

Dec. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

17. Commitments and Contingencies

Operating Leases

Financial Assurance:

Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)	6 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of these condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. The Company regularly evaluates estimates and assumptions related to the fair value of stock-based compensation, valuation and recoverability of long-lived assets and intangible assets subject to impairment testing, and deferred income tax asset valuation allowances.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2024 and June 30, 2024. AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements (unaudited)
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is an exit price concept that assumes an orderly transaction between willing market participants and is required to be based on assumptions that market participants would use in pricing an asset or a liability. Current accounting guidance establishes a three-tier fair value hierarchy as a basis for considering such assumptions and for classifying the inputs used in the valuation methodologies. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair values are as follows: Level 1: Quoted prices (unadjusted) in active markets for identical assets and liabilities that the reporting entity can assess at the measurement date. Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 3: Unobservable inputs for the asset or liability which include the Company’s assumptions regarding the data market participants would use in pricing the asset or liability based on the best information available under the circumstances. The carrying values of the Company’s cash, accounts receivable, prepaid expenses and deposits, notes payable, accounts payable and accrued liabilities approximate fair value due to their short maturities. The Company’s recurring fair value measurements include the valuation of the derivative liabilities for the bifurcated notes payable freestanding call and conversion options and for the liability-classified equity-linked contracts, both of which are classified as Level 3 of the fair value hierarchy. See Notes 6 and 11 for relevant fair value disclosures. Given use of unobservable inputs, there is inherently uncertainty that the inputs could reasonably have been different as of the reporting date. The Company’s non-recurring fair value measurements include the valuation of the assets held-for-sale as of December 31, 2024. See Note 7 for relevant fair value disclosures.
Adoption of Recent Accounting Pronouncements	Adoption of Recent Accounting Pronouncements The Company continually assesses new accounting pronouncements to determine their applicability. When it is determined a new accounting pronouncement affects the Company’s financial reporting, the Company undertakes a review to determine the consequences of the change to its consolidated financial statements and assures there are sufficient controls in place to ascertain the Company’s consolidated financial statements properly reflect the change. In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, “Segment Reporting - Improvements to Reportable Segment Disclosures”, which updates reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses and information used to assess segment performance. The amendments in this ASU are effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is in the process of determining the effect this ASU will have on the disclosures contained in the notes to the consolidated financial statements. In December 2023, the FASB issued ASU 2023-09, “Improvements to Income Tax Disclosures”, which updates income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This ASU also includes certain other amendments to improve the effectiveness of income tax disclosures. The amendments in this ASU are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The Company is in the process of determining the effect this ASU will have on the disclosures contained in the notes to the consolidated financial statements. AMERICAN BATTERY TECHNOLOGY COMPANY Notes to the Condensed Consolidated Financial Statements (unaudited) In November 2024, the FASB Issued ASU 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” The amendments in this update require disclosures, in the notes to financial statements, of specified information about certain costs and expenses. The amendment clarifies which certain costs and expenses that are included in cost of sales and selling, general, and administrative expense categories that should be disclosed with qualitative descriptions of amounts that are not separately disaggregated quantitatively. Additionally, the amendment requires disclosure of total amounts of selling expenses and an entity’s definition of selling expense. The update will be effective for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is in the process of determining the effect this ASU will have on the disclosures contained in the notes to the consolidated financial statements.

Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)

6 Months Ended

Dec. 31, 2024

Accounting Policies [Abstract]

Schedule of Consolidated Financial Statements

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

	As Reported			Adjustments			As Corrected
	Three months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Operating expenses
General and administrative	$	4,310,452		$	106,264		$	4,416,716
Research and development		3,148,873			420,294			3,569,167
Exploration		771,523			51,902			823,425
Total operating expenses		8,230,848			578,460			8,809,308

Net loss before other income (expense)	$	(8,230,848	)	$	(578,460	)	$	(8,809,308	)

Other income (expense)
Amortization and accretion of financing costs	$	(1,053,766	)	$	(78,492	)	$	(1,132,258	)
Change in fair value of derivative liability		-			(229,472	)		(229,472	)
Total other income (expense)		(1,060,587	)		(307,965	)		(1,368,551	)

Net loss attributable to common stockholders	$	(9,291,435	)	$	(886,424	)	$	(10,177,859	)
Net loss per share, basic and diluted	$	(0.19	)	$	(0.02	)	$	(0.21	)

	As Reported			Adjustments			As Corrected
	Six months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Operating expenses
General and administrative	$	7,259,298		$	211,415		$	7,470,713
Research and development		5,304,187			1,878,831			7,183,018
Exploration		2,051,305			122,040			2,173,345
Total operating expenses		14,614,790			2,212,286			16,827,076

Net loss before other income (expense)	$	(14,614,790	)	$	(2,212,286	)	$	(16,827,076	)

Other income (expense)
Amortization and accretion of financing costs	$	(1,760,497	)	$	(104,657	)	$	(1,865,154	)
Change in fair value of derivative liability		-			(229,473	)		(229,473	)
Total other income (expense)		(1,908,630	)		(334,130	)		(2,242,760	)

Net loss attributable to common stockholders	$	(16,523,420	)	$	(2,546,416	)	$	(19,069,836	)
Net loss per share, basic and diluted	$	(0.35	)	$	(0.05	)	$	(0.40	)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

	As Reported			Adjustments			As Corrected
	Three months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Stockholders’ Equity

Additional paid-in capital:
Stock-based compensation expense		3,836,466			424,861			4,261,327
Balance, December 31, 2023	$	243,020,935		$	2,380,621		$	245,401,556

Accumulated deficit
Net loss for period		(9,291,435	)		(886,424	)		(10,177,859	)
Balance, December 31, 2023	$	(176,496,995	)	$	(3,399,350	)	$	(179,896,345	)

Total stockholders’ equity
Balance, December 31, 2023	$	66,573,285		$	(1,018,729	)	$	65,554,556

AMERICAN BATTERY TECHNOLOGY COMPANY

Notes to the Condensed Consolidated Financial Statements

(unaudited)

	As Reported			Adjustments			As Corrected
	Six months ended December 31, 2023
	As Reported			Adjustments			As Corrected

Stockholders’ Equity

Additional paid-in capital:
Stock-based compensation expense		5,757,908			1,872,688			7,630,596
Balance, December 31, 2023	$	243,020,935		$	2,380,621		$	245,401,556

Accumulated deficit
Net loss for period		(16,523,420	)		(2,546,416	)		(19,069,836	)
Balance, December 31, 2023	$	(176,496,995	)	$	(3,399,350	)	$	(179,896,345	)

Total stockholders’ equity
Balance, December 31, 2023	$	66,573,285		$	(1,018,729	)	$	65,554,556

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

	As Reported			Adjustments			As Corrected
	Six months ended December 31, 2023
	As Reported			Adjustments			As Corrected
Operating Activities
Net loss attributable to stockholders	$	(16,523,420	)	$	(2,546,416	)	$	(19,069,836	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and accretion expense	$	1,760,497		$	104,657		$	1,865,154
Stock-based compensation		5,757,908			1,933,603			7,691,511
Shares issued for professional services		(132	)		(316	)		(448	)
Change in fair value of derivative liability		-			229,473			229,473
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities	$	2,164,539		$	279,000		$	2,443,539

Net cash used in operating activities	$	(7,418,700	)	$	-		$	(7,418,700	)

Inventories (Tables)

6 Months Ended

Dec. 31, 2024

Inventory Disclosure [Abstract]

Schedule of Inventories

	December 31, 2024		June 30, 2024
Raw materials	$	449,665	$	66,088
Finished goods		124,438		88,232
Total	$	574,103	$	154,320

Derivative Liabilities (Tables)

6 Months Ended

Dec. 31, 2024

Derivative Liabilities

Schedule of Black-Scholes Inputs and Assumptions for valuation and Re-valuation of its Derivative Liabilities

The table below sets forth the Black-Scholes inputs and assumptions for the Company’s valuation and re-valuation of its derivative liabilities for the three months ending December 31:

	2024
Weighted average expected term (years)		0.01 – 4.67
Risk-free interest rate		4.26% - 4.69	%
Dividend yield		0	%
Volatility		6.69% - 117.89	%

Schedule of Derivative Liabilities

A summary of the activity related to derivative liabilities for the three months ending December 31, 2024, is as follows:

Schedule of Derivative Liabilities

	Warrant Derivative Liabilities			Conversion Option Derivative Liability			Total Derivative Liabilities

Balance, September 30, 2024	$	3,117,647		$	939,435		$	4,057,082
Change in fair value		(639,727	)		(388,365	)		(1,028,092	)
Fair value of extinguishments during the period		(87,421	)		-			(87,421	)
Fair value of reclassifications to accounts payable during the period		(875,000	)		-			(875,000	)
Fair value of reclassifications to equity during the period		(1,515,499	)		(551,070	)		(2,066,569	)
Balance, December 31, 2024	$	-		$	-		$	-

Property, Plant and Equipment (Tables)

6 Months Ended

Dec. 31, 2024

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment

The table below presents the property, plant and equipment as of December 31, 2024 and June 30, 2024:

Schedule of Property and Equipment

	December 31, 2024			June 30, 2024
Land	$	8,860,916		$	8,860,916
Building		16,633,661			24,867,784
Equipment and vehicles		23,232,967			14,313,970
Total property, plant and equipment		48,727,544			48,042,670
Less: accumulated depreciation		(4,192,864	)		(1,727,704	)
Property, plant and equipment, net		44,534,680		$	46,314,966

Intangible Assets (Tables)

6 Months Ended

Dec. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

The table below presents total intangible assets at:

Schedule of Intangible Assets

		December 31, 2024				June 30, 2024
Water rights		$	4,519,038			$	4,519,038

Accounts Payable and Accrued Liabilities (Tables)

6 Months Ended

Dec. 31, 2024

Payables and Accruals [Abstract]

Schedule of Accounts Payable and Accrued Liabilities

The table below presents total accounts payable and accrued liabilities at:

	December 31, 2024		June 30, 2024
Trade payables	$	2,038,587	$	4,255,398
Accrued fixed assets		225,104		996,970
Accrued expenses		4,903,723		2,244,265
Market agreement settlement		-		1,800,000
Total accounts payable and accrued liabilities	$	7,167,414	$	9,296,633

Notes Payable (Tables)

6 Months Ended

Dec. 31, 2024

Debt Disclosure [Abstract]

Schedule of Net Carrying Amounts of the Notes

The table below presents the net carrying amounts of the 2024 Notes as of:

	December 31, 2024
Principal outstanding	$	12,000,000
Debt discount		(2,243,790	)
Amortization of debt discount		409,167
Net carrying value	$	10,165,377

Schedule of Maturities of Notes Payable

The table below presents the maturities of notes payable as of December 31, 2024:

Schedule of Maturities of Notes Payable


December 31, 2024	$	12,000,000
Less: unamortized debt discount and issuance costs		(1,834,623	)
Total notes payable	$	10,165,377

Notes payable, current	$	10,165,377
Notes payable, non-current	$	-

Leases (Tables)

6 Months Ended

Dec. 31, 2024

Leases

Schedule of Operating Lease ROU Assets and Lease Liabilities

	December 31, 2024		June 30, 2024
Operating lease right-of-use asset	$	357,431	$	42,103
Operating lease liabilities	$	359,015	$	54,304

Schedule of Maturity of Operating Lease Liabilities

The table below presents the maturities of operating lease liabilities as of December 31, 2024:


December 31, 2025	$	133,413
December 31, 2026		139,011
December 31, 2027		132,130
Total lease payments		404,554
Less: discount		(45,539	)

Total operating lease liabilities	$	359,015

Operating lease liabilities, current	$	108,600
Operating lease liabilities, non-current	$	250,416

Schedule of Weighted Average Remaining Lease Term for Operating Leases and Weighted Average Discount Rate

Weighted average lease term (years)			2.83
Weighted average discount rate			8.00	%

Stockholders’ Equity (Tables)

6 Months Ended

Dec. 31, 2024

Equity [Abstract]

Schedule of Potentially Dilutive Shares Outstanding

The Company had the following potentially dilutive shares outstanding as of December 31:

	2024		2023
Convertible notes		13,282,344		1,942,363
Warrants		16,138,037		5,731,666
Share awards outstanding		8,052,791		2,871,252
Total potentially dilutive		37,473,172		10,545,281

Share Purchase Warrants (Tables)

6 Months Ended

Dec. 31, 2024

Share Purchase Warrants

Schedule of Share Purchase Warrants Activity

	Number of Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value

Balance, June 30, 2024		6,928,758		$	12.95
Granted		3,548,426			1.01
Exercised		-			-
Expired		(1,082,715	)		12.02
Balance, September 30, 2024		9,394,469		$	8.55
Granted		8,969,762			1.90
Exercised		-			-
Rescinded		(1,750,000	)		1.00
Expired		(476,194	)		10.50
Balance, December 31, 2024		16,138,037		$	5.61		4.12	$	-
Exercisable, December 31, 2024		15,365,150		$	4.53		4.08	$	-

Equity Compensation Awards (Tables)

6 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Restricted Shares and Restricted Share Units Non-vested

The table below reflects the share award activity for the period ended December 31, 2024:

	Units			Weighted- Average Grant Date Fair Value per Unit

Unvested share awards at June 30, 2024		3,428,604		$	5.02
Granted		185,742			1.00
Vested		(410,504	)		4.10
Forfeitures		(26,875	)	$	5.22
Unvested share awards at September 30, 2024		3,176,967		$	4.90
Granted		5,822,024			0.96
Vested		(924,430	)		2.43
Forfeitures		(21,770	)	$	6.76
Unvested awards at December 31, 2024		8,052,791		$	2.33

Schedule of Stock-Based Compensation Expense

The table below presents the stock-based compensation expense per respective line item on the condensed consolidated statements of operations for the six months ended December 31:

	2024		2023

Cost of goods sold	$	267,449	$	-
General and administrative		6,836,740		4,083,070
Research and development		2,295,427		2,659,061
Exploration		102,417		949,380
Total stock-based compensation	$	9,502,030	$	7,691,511

Supplemental Statement of Cash Flow Disclosures (Tables)

6 Months Ended

Dec. 31, 2024

Supplemental Cash Flow Elements [Abstract]

Schedule of Statement of Cash Flow Disclosures

For the six months ended December 31:

	2024		2023

Supplemental disclosures:

Interest paid	$	4,575	$	14,462

Non-cash investing and financing activities:

Purchases of property and equipment accrued in current liabilities		225,104		-
Deposits capitalized as investing activities		-		27,103,351
Right-of-use asset obtained in exchange for lease liability		367,643		-
Debt payment satisfied with common shares		1,742,580		-
Payable recognized upon rescission of subscription agreement		875,000		-

Liquidity and Going Concern (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended
	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ 10,177,859	$ 25,100,000	$ 19,069,836
Net cash used in operating activities		12,815,978	$ 7,418,700
Cash balance		20,600,000
Cash		15,623,762		$ 7,001,786
Restricted cash current		5,000,000
Accumulated deficit		$ 238,423,407		$ 213,328,332

Schedule of Consolidated Financial Statements (Details) - USD ($)	3 Months Ended				6 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2024	Dec. 31, 2023
Operating expenses
General and administrative	$ 7,673,022		$ 4,416,716		$ 12,682,863	$ 7,470,713
Research and development	2,919,865		3,569,167		4,952,000	7,183,018
Exploration	234,568		823,425		655,075	2,173,345
Total operating expenses	10,827,455		8,809,308		18,289,938	16,827,076
Net loss before other income (expense)	(13,800,758)		(8,809,308)		(23,603,922)	(16,827,076)
Other income (expense)
Amortization and accretion of financing costs			(1,132,258)			(1,865,154)
Change in fair value of derivative liability			(229,472)			(229,473)
Total other income (expense)	400,252		(1,368,551)		(1,491,153)	(2,242,760)
Net loss attributable to stockholders			(10,177,859)		(25,100,000)	(19,069,836)
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition	6,330,914	$ 2,420,747	4,261,327	$ 3,369,269
Balance	70,597,046	59,344,596	65,554,556	58,638,365	70,597,046	65,554,556
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and accretion expense					1,904,546	1,865,154
Stock-based compensation					9,502,030	7,691,511
Shares issued for professional services						(448)
Change in fair value of derivative liability			229,472			229,473
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities						2,443,539
Net Cash Used in Operating Activities					(12,815,978)	(7,418,700)
Additional Paid-in Capital [Member]
Other income (expense)
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition	6,330,914	2,420,747	4,261,327	3,369,269		7,630,596
Balance	310,351,869	285,607,121	245,401,556	228,273,045	310,351,869	245,401,556
Retained Earnings [Member]
Other income (expense)
Net loss attributable to stockholders			(10,177,859)			(19,069,836)
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition
Balance	$ (238,423,407)	$ (225,022,901)	(179,896,345)	$ (169,718,486)	$ (238,423,407)	(179,896,345)
Previously Reported [Member]
Operating expenses
General and administrative			4,310,452			7,259,298
Research and development			3,148,873			5,304,187
Exploration			771,523			2,051,305
Total operating expenses			8,230,848			14,614,790
Net loss before other income (expense)			(8,230,848)			(14,614,790)
Other income (expense)
Amortization and accretion of financing costs			(1,053,766)			(1,760,497)
Change in fair value of derivative liability
Total other income (expense)			(1,060,587)			(1,908,630)
Net loss attributable to stockholders			(9,291,435)			(16,523,420)
Balance			66,573,285			66,573,285
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and accretion expense						1,760,497
Stock-based compensation						5,757,908
Shares issued for professional services						(132)
Change in fair value of derivative liability
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities						2,164,539
Net Cash Used in Operating Activities						(7,418,700)
Previously Reported [Member] \| Additional Paid-in Capital [Member]
Other income (expense)
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition			3,836,466			5,757,908
Balance			243,020,935			243,020,935
Previously Reported [Member] \| Retained Earnings [Member]
Other income (expense)
Net loss attributable to stockholders			(9,291,435)			(16,523,420)
Balance			(176,496,995)			(176,496,995)
Revision of Prior Period, Reclassification, Adjustment [Member]
Operating expenses
General and administrative			106,264			211,415
Research and development			420,294			1,878,831
Exploration			51,902			122,040
Total operating expenses			578,460			2,212,286
Net loss before other income (expense)			(578,460)			(2,212,286)
Other income (expense)
Amortization and accretion of financing costs			(78,492)			(104,657)
Change in fair value of derivative liability			(229,472)			(229,473)
Total other income (expense)			(307,965)			(334,130)
Net loss attributable to stockholders			(886,424)			(2,546,416)
Balance			(1,018,729)			(1,018,729)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization and accretion expense						104,657
Stock-based compensation						1,933,603
Shares issued for professional services						(316)
Change in fair value of derivative liability			229,472			229,473
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities						279,000
Net Cash Used in Operating Activities
Revision of Prior Period, Reclassification, Adjustment [Member] \| Additional Paid-in Capital [Member]
Other income (expense)
APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition			424,861			1,872,688
Balance			2,380,621			2,380,621
Revision of Prior Period, Reclassification, Adjustment [Member] \| Retained Earnings [Member]
Other income (expense)
Net loss attributable to stockholders			(886,424)			(2,546,416)
Balance			$ (3,399,350)			$ (3,399,350)

Condensed Consolidated Statement of Operations (Details) - $ / shares	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Net loss per share, basic	$ (0.18)	$ (0.21)	$ (0.35)	$ (0.40)
Net loss per share, diluted	$ (0.18)	(0.21)	$ (0.35)	(0.40)
Previously Reported [Member]
Net loss per share, basic		(0.19)		(0.35)
Net loss per share, diluted		(0.19)		(0.35)
Revision of Prior Period, Reclassification, Adjustment [Member]
Net loss per share, basic		(0.02)		(0.05)
Net loss per share, diluted		$ (0.02)		$ (0.05)

Basis of Presentation, Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended
	Dec. 31, 2023	Dec. 31, 2023	Dec. 31, 2024	Jun. 30, 2024
Increase in accounts payable and accrued liabilities			$ 7,167,414	$ 9,233,806
Equity compensation liability	$ 100,000	$ 100,000		$ 409,194
Interest and other expenses	300,000	400,000
Revision of Prior Period, Error Correction, Adjustment [Member]
Increase in compensation cost	600,000	2,200,000
Increase in accounts payable and accrued liabilities	300,000	300,000
Increase in additional paid-in capital	$ 1,800,000	$ 1,800,000

Schedule of Inventories (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Inventory Disclosure [Abstract]
Raw materials	$ 449,665	$ 66,088
Finished goods	124,438	88,232
Total	$ 574,103	$ 154,320

Government Grants and Tax Credit Awards (Details Narrative) - USD ($)	Mar. 28, 2024	Nov. 17, 2022	Oct. 21, 2022	Aug. 16, 2021	Jan. 20, 2021	Dec. 31, 2024	Dec. 18, 2024	Sep. 23, 2024	Jun. 30, 2024
Government grants						$ 27,000		$ 150,000,000	$ 200,000
Project budget		$ 20,000,000.0	$ 115,500,000
Tac credit	$ 19,500,000
Additional tax credit	$ 40,500,000
September 1, 2023 [Member]
Government grant cumulative funds invoiced						$ 3,200,000
Percentage of net eligible reimbursements						6.00%
October 1, 2023 [Member]
Government grant cumulative funds invoiced						$ 1,100,000
Percentage of net eligible reimbursements						11.00%
Maximum [Member]
Reimbursement percentage		50.00%	50.00%
Reimbursement of eligible expenditure		$ 10,000,000.0	$ 57,700,000
AMMTO Grant [Member]
Project budget					$ 4,500,000
AMMTO Grant [Member] \| October 1, 2021 [Member]
Government grant cumulative funds invoiced						$ 2,000,000.0
Percentage of net eligible reimbursements						90.00%
AMMTO Grant [Member] \| Maximum [Member]
Reimbursement percentage					50.00%
Reimbursement of eligible expenditure					$ 2,300,000
USABC Grant [Member]
Project budget				$ 2,000,000.0
Government grant cumulative funds invoiced						$ 500,000
Percentage of net eligible reimbursements						100.00%
USABC Grant [Member] \| Maximum [Member]
Reimbursement of eligible expenditure				$ 500,000
Subcontractor Argonne National Laboratory [Member]
Investments							$ 144,000,000
Research and Development Expense [Member]
Government grants						$ 2,300,000

Schedule of Black-Scholes Inputs and Assumptions for valuation and Re-valuation of its Derivative Liabilities (Details)	Dec. 31, 2024
Measurement Input, Expected Term [Member] \| Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability	0.01
Measurement Input, Expected Term [Member] \| Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability	4.67
Measurement Input, Risk Free Interest Rate [Member] \| Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability	0.0426
Measurement Input, Risk Free Interest Rate [Member] \| Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability	0.0469
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability	0
Measurement Input, Price Volatility [Member] \| Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability	0.0669
Measurement Input, Price Volatility [Member] \| Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability	1.1789

Schedule of Derivative Liabilities (Details)	3 Months Ended
Schedule of Derivative Liabilities (Details)	Dec. 31, 2024 USD ($)
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Balance, September 30, 2024	$ 4,057,082
Change in fair value	(1,028,092)
Fair value of extinguishments during the period	(87,421)
Fair value of reclassifications to accounts payable during the period	(875,000)
Fair value of reclassifications to equity during the period	(2,066,569)
Balance, December 31, 2024
Warrant Derivative Liabilities [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Balance, September 30, 2024	3,117,647
Change in fair value	(639,727)
Fair value of extinguishments during the period	(87,421)
Fair value of reclassifications to accounts payable during the period	(875,000)
Fair value of reclassifications to equity during the period	(1,515,499)
Balance, December 31, 2024
Conversion Option Derivative Liability [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Balance, September 30, 2024	939,435
Change in fair value	(388,365)
Fair value of extinguishments during the period
Fair value of reclassifications to accounts payable during the period
Fair value of reclassifications to equity during the period	(551,070)
Balance, December 31, 2024

Derivative Liabilities (Details Narrative) - USD ($)		1 Months Ended			3 Months Ended			6 Months Ended
Derivative Liabilities (Details Narrative) - USD ($)	Nov. 30, 2024	Nov. 30, 2024	Sep. 30, 2024	Aug. 31, 2024	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Share-Based Payment Arrangement, Noncash Expense								$ 9,502,030	$ 7,691,511
Loss on private placement								(567,161)
Fair value of liability			$ 200,000			$ 200,000
Gain on warrant liability						700,000		705,184	$ (229,473)
Accounts payable and accrued liabilities					$ 7,167,414			$ 7,167,414		$ 9,296,633
Fair value of the bifurcated conversion feature			700,000
Fair value of convertible notes			$ 900,000			900,000
Common Stock, Shares Authorized					250,000,000			250,000,000		250,000,000
Gain on change in fair value of the derivative liabilities		$ 800,000
Long-Term Debt	$ 2,100,000	$ 2,100,000
Maximum [Member]
Common Stock, Shares Authorized	250,000,000	250,000,000
Minimum [Member]
Common Stock, Shares Authorized	80,000,000	80,000,000
Private Placement Subscription Agreement [Member]
Proceeds from Issuance of Private Placement				$ 1,900,000
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants				1,400,000
Share-Based Payment Arrangement, Noncash Expense				700,000
Loss on private placement				100,000		100,000
Fair value of liability				100,000
Fair value of warrants				1,700,000		$ 1,700,000
Loss in private placement				600,000
Gain on warrant liability	$ 100,000
Accounts payable and accrued liabilities					$ 900,000			$ 900,000
Private Placement Subscription Agreement [Member] \| Warrant [Member]
Gain on warrant liability	300,000
Private Placement Subscription Agreement [Member] \| Warrant [Member] \| Maximum [Member]
Warrant liability	1,200,000	$ 1,200,000
Private Placement Subscription Agreement [Member] \| Warrant [Member] \| Minimum [Member]
Warrant liability	$ 900,000	$ 900,000
Private Placement Subscription Agreement [Member] \| Related Party [Member]
Proceeds from Issuance of Private Placement				$ 600,000

Schedule of Property and Equipment (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	$ 48,727,544	$ 48,042,670
Less: accumulated depreciation	(4,192,864)	(1,727,704)
Property, plant and equipment, net	44,534,680	46,314,966
Land [Member]
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	8,860,916	8,860,916
Building [Member]
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	16,633,661	24,867,784
Equipment and Vehicles [Member]
Property, Plant and Equipment [Line Items]
Total property, plant and equipment	$ 23,232,967	$ 14,313,970

Property, Plant and Equipment (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 1,200,000	$ 44,908	$ 2,500,000	$ 81,410
Impairment of Long-Lived Assets to be Disposed of					$ 10,300,000
Land and Building [Member]
Property, Plant and Equipment [Line Items]
Long-Lived Asset, Held-for-Sale, Fair Value Disclosure	18,600,000		18,600,000
Water Rights [Member]
Property, Plant and Equipment [Line Items]
Long-Lived Asset, Held-for-Sale, Fair Value Disclosure	$ 100,000		$ 100,000

Mining Properties (Details Narrative) $ in Millions	1 Months Ended
Mining Properties (Details Narrative) $ in Millions	Dec. 31, 2023 USD ($)	Sep. 12, 2023 a	Aug. 21, 2023 a	Jul. 22, 2023 ft²
Mining Properties
Land		40.52	18.45	6,500
Capitalized minig assets	$ 0.2

Schedule of Intangible Assets (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Water Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Water rights	$ 4,519,038	$ 4,519,038

Intangible Assets (Details Narrative) $ in Millions	Sep. 12, 2023 USD ($) a	Aug. 21, 2023 USD ($) a	Jul. 22, 2023 ft²
Goodwill and Intangible Assets Disclosure [Abstract]
Area of land	40.52	18.45	6,500
Payments to acquire intangible assets	$ 0.1	$ 0.7

Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Payables and Accruals [Abstract]
Trade payables	$ 2,038,587	$ 4,255,398
Accrued fixed assets	225,104	996,970
Accrued expenses	4,903,723	2,244,265
Market agreement settlement		1,800,000
Total accounts payable and accrued liabilities	$ 7,167,414	$ 9,296,633

Accounts Payable and Accrued Liabilities (Details Narrative) - USD ($) $ in Millions	Jul. 03, 2024	Jun. 30, 2024
Payables and Accruals [Abstract]
Accounts Payable, Current	$ 0.3
Accrued Liabilities, Current		$ 1.8

Schedule of Net Carrying Amounts of the Notes (Details)	Dec. 31, 2024 USD ($)
Debt Disclosure [Abstract]
Principal outstanding	$ 12,000,000
Debt discount	(2,243,790)
Amortization of debt discount	409,167
Net carrying value	$ 10,165,377

Schedule of Maturities of Notes Payable (Details)	Dec. 31, 2024 USD ($)
Debt Disclosure [Abstract]
December 31, 2024	$ 12,000,000
Less: unamortized debt discount and issuance costs	(1,834,623)
Net carrying value	10,165,377
Notes payable, current	10,165,377
Notes payable, non-current

Notes Payable (Details Narrative) - USD ($)				3 Months Ended			6 Months Ended
Notes Payable (Details Narrative) - USD ($)	Dec. 19, 2024	Nov. 14, 2024	Aug. 29, 2023	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Sep. 13, 2024	Jun. 30, 2024
Debt Instrument [Line Items]
Derivative Liability, Fair Value of Collateral				$ 400,000			$ 400,000
Derivative, Gain (Loss) on Derivative, Net					$ 700,000		705,184	$ (229,473)
Principal amount				$ 12,000,000			$ 12,000,000
Number of shares issued				84,392,375			84,392,375			64,061,763
Loss on extinguishment of debt							$ (675,648)
Amortization of the debt discount				400,000
Cash				$ 15,623,762			$ 15,623,762			$ 7,001,786
Common Stock [Member]
Debt Instrument [Line Items]
Debt conversion, shares	1,333.33
Debt conversion, value	$ 1,000
2024 Notes [Member] \| Common Stock [Member] \| First Principal [Member]
Debt Instrument [Line Items]
Principal amount		$ 3,000,000
Conversion of Stock, Shares Converted		1,333.33
Conversion of Stock, Amount Issued		$ 1,000
2024 Notes [Member] \| Common Stock [Member] \| Remaining Principal [Member]
Debt Instrument [Line Items]
Conversion of Stock, Shares Converted		945.0992
Conversion of Stock, Amount Issued		$ 1,000
Maximum [Member] \| Common Stock [Member]
Debt Instrument [Line Items]
Principal amount	5,000,000
Minimum [Member] \| Common Stock [Member]
Debt Instrument [Line Items]
Principal amount	$ 3,000,000
Purchase Agreement [Member]
Debt Instrument [Line Items]
Proceeds from secured notes payable			$ 25,000,000.0
Principal amount		12,000,000.0							$ 600,000
Number of shares issued				726,216,000,000			726,216,000,000
Number of shares issued, value							$ 700,000
Loss on extinguishment of debt							700,000
Amortization of the debt discount							600,000
Fair value of common share				$ 100,000			$ 100,000
Debt Instrument, Unamortized Discount		2,100,000
Interest rate				50.73%			50.73%
Purchase Agreement [Member] \| 2024 Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Annual Principal Payment		1,100,000
Proceeds from (Repayments of) Debt		$ 1,800,000
Debt Instrument, Maturity Date		Sep. 01, 2025
Cash		$ 5,000,000.0
Debt Instrument, Periodic Payment		$ 1,000,000.0
Purchase Agreement [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Proceeds from secured notes payable			$ 51,000,000.0

Schedule of Operating Lease ROU Assets and Lease Liabilities (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Leases
Operating lease right-of-use asset	$ 357,431	$ 42,103
Operating lease liabilities	$ 359,015	$ 54,304

Schedule of Maturity of Operating Lease Liabilities (Details) - USD ($)	Dec. 31, 2024	Jun. 30, 2024
Leases
December 31, 2025	$ 133,413
December 31, 2026	139,011
December 31, 2027	132,130
Total lease payments	404,554
Less: discount	(45,539)
Total operating lease liabilities	359,015	$ 54,304
Operating lease liabilities, current	108,600	117,131
Operating lease liabilities, non-current	$ 250,416

Schedule of Weighted Average Remaining Lease Term for Operating Leases and Weighted Average Discount Rate (Details)	Dec. 31, 2024
Leases
Weighted average lease term (years)	2 years 9 months 29 days
Weighted average discount rate	8.00%

Leases (Details Narrative) - USD ($) $ in Millions	6 Months Ended
Leases (Details Narrative) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Leases
Percentage of discount rate	8.00%	8.00%
Operating lease costs	$ 0.1	$ 0.1
Current lease liabilities	$ 0.1

Schedule of Potentially Dilutive Shares Outstanding (Details) - shares	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive	37,473,172	10,545,281
Convertible Notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive	13,282,344	1,942,363
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive	16,138,037	5,731,666
Share Awards Outstanding [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive	8,052,791	2,871,252

Stockholders’ Equity (Details Narrative) - USD ($)							3 Months Ended		6 Months Ended
Stockholders’ Equity (Details Narrative) - USD ($)	Dec. 27, 2024	Dec. 23, 2024	Nov. 13, 2024	Sep. 16, 2024	Aug. 01, 2024	Jul. 22, 2024	Dec. 31, 2024	Sep. 30, 2023	Dec. 31, 2024	Nov. 30, 2024	Jun. 30, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized							250,000,000		250,000,000		250,000,000
Common stock par value							$ 0.001		$ 0.001		$ 0.001
Class of warrant or right, outstanding						600,000
Exercise price						$ 1.125
Volatility rate						100.47%
Risk-free rate						5.06%
Fair value of warrants							$ 1,900,000		$ 1,900,000
Share based compensation									9,500,000
Adjustments of additional paid in capital									8,800,000
Equity compensation liability							100,000		100,000
Share based compensation expense									$ 700,000
Employee stock purchase plan, value							$ 140,746
Private Placement Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, value					$ 1,000,000.0
Sale of Stock, consideration received					1,900,000
2024 Employee Stock Purchase Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Employee stock purchase plan, shares			177,440
Employee stock purchase plan, value			$ 100,000
Professional Service Providers [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued for professional services, shares									1,426,620
Ryan Melsert [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of warrant or right, outstanding						200,000
Advances, fair value disclosure						$ 100,000
Family Members [Member] \| Private Placement Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of Stock, consideration received					25,000
Employees [Member] \| Private Placement Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of Stock, consideration received					$ 25,000
Minimum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized										80,000,000
Maximum [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized										250,000,000
Series ABC And D Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized							233,334		233,334
Series D Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized											5
Preferred stock, shares outstanding							5		5
Preferred stock, shares issued							5		5
Sale of stock, shares				5
Preferred stock, par value				$ 0.001							$ 0.001
Sale of stock, value			$ 100	$ 100
Sale of stock, per share price				$ 20
Preferred stock voting rights				Each share of Series D Preferred Stock had 12,000,000 votes and voted together with the outstanding shares of the Company’s common stock as a single class exclusively with respect to a proposal to amend the Company’s articles of incorporation, as amended, to increase the number of authorized shares of common stock of the Company.
Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized							33,334		33,334		33,334
Preferred stock, shares outstanding
Preferred stock, shares issued
Preferred stock, par value							$ 0.001		$ 0.001		$ 0.001
Series B Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized							133,334		133,334		133,334
Preferred stock, shares outstanding
Preferred stock, shares issued
Preferred stock, par value							$ 10.00		$ 10.00		$ 10.00
Series C Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized							66,667		66,667		66,667
Preferred stock, shares outstanding
Preferred stock, shares issued
Preferred stock, par value							$ 10.00		$ 10.00		$ 10.00
Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized							1,666,667		1,666,667
Employee stock purchase plan, shares
Employee stock purchase plan, value
Preferred Stock [Member] \| Series D Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized							5		5		5
Preferred stock, shares outstanding
Preferred stock, shares issued
Preferred stock, par value							$ 0.001		$ 0.001		$ 0.001
Preferred Stock [Member] \| Series A Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized							33,334		33,334		33,334
Preferred stock, shares outstanding
Preferred stock, shares issued
Preferred stock, par value							$ 0.001		$ 0.001		$ 0.001
Preferred Stock [Member] \| Series B Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized							133,334		133,334		133,334
Preferred stock, shares outstanding
Preferred stock, shares issued
Preferred Stock [Member] \| Series C Preferred Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares authorized							66,667		66,667		66,667
Preferred stock, shares outstanding
Preferred stock, shares issued
Preferred stock, par value							$ 10.00		$ 10.00		$ 10.00
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued for professional services, shares								1,326
Employee stock purchase plan, value							$ 178
Common Stock [Member] \| Family Members [Member] \| Private Placement Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, shares					25,000
Common Stock [Member] \| Employees [Member] \| Private Placement Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of stock, shares					19,531
Common Stock [Member] \| Two Institutional Investors [Member] \| Securities Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of warrant or right, outstanding	3,773,586	5,000,000
Shares issued	3,773,586	5,000,000
Offering price	$ 2.65	$ 1.00
Warrants exercise price	$ 2.80	$ 1.10
Initial exercise date description	exercisable immediately from the date of issuance and will expire five years from the initial exercise date.	exercisable immediately from the date of issuance and expire five years from the initial exercise date.
Total proceeds	$ 15,000,000.0
Net offering costs	$ 1,100,000
Series A Warrants [Member] \| Family Members [Member] \| Private Placement Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of warrants, shares					25,000
Series A Warrants [Member] \| Employees [Member] \| Private Placement Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of warrants, shares					39,062
Series B Warrants [Member] \| Family Members [Member] \| Private Placement Subscription Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of warrants, shares					25,000
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of warrant or right, outstanding							898,426		898,426
Shares issued									1,936,576
Shares issued value									$ 1,600,000
Warrant [Member] \| Securities Purchase Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Class of warrant or right, outstanding							8,773,586		8,773,586
Warrant [Member] \| Employees [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued value									$ 3,548,426

Schedule of Share Purchase Warrants Activity (Details) - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2024
Share Purchase Warrants
Number of warrants, Beginning Balance	9,394,469	6,928,758	6,928,758
Weighted average exercise price, Beginning Balance	$ 8.55	$ 12.95	$ 12.95
Number of warrants, Granted	8,969,762	3,548,426
Weighted average exercise price, Granted	$ 1.90	$ 1.01
Number of warrants, Exercised
Weighted average exercise price, Exercised
Weighted average exercise price, Expired	$ 10.50	$ 12.02
Number of warrants, Rescinded	(1,750,000)
Weighted average exercise price, Rescinded	$ 1.00
Number of warrants, Expired	(476,194)
Number of warrants, Ending Balance	16,138,037	9,394,469	16,138,037
Weighted average exercise price, Ending Balance	$ 5.61	$ 8.55	$ 5.61
Weighted average remaining contractual term, Ending balance	4 years 1 month 13 days		4 years 1 month 13 days
Aggregate intrincic value outstanding, Ending balance
Number of warrants, Exercisable	15,365,150		15,365,150
Weighted average exercise price, Exercisable	$ 4.53		$ 4.53
Weighted average remaining contractual term, Exercisable			4 years 29 days
Aggregate intrincic value exercisable

Share Purchase Warrants (Details Narrative) - USD ($)	3 Months Ended	6 Months Ended
Share Purchase Warrants (Details Narrative) - USD ($)	Dec. 31, 2024	Dec. 31, 2024	Jul. 22, 2024
Warrants with securities purchase agreement			600,000
Cancellation of warrants	1,750,000
Employees [Member]
Cancellation of warrants		1,750,000
Warrant [Member]
Warrant exercised		12,518,188
Warrants to the private placement		$ 1,600,000
Warrants with securities purchase agreement	898,426	898,426
Warrants under compensation	$ 196,176	$ 196,176
Warrant [Member] \| Securities Purchase Agreement [Member]
Warrants with securities purchase agreement	8,773,586	8,773,586
Warrant [Member] \| Employees [Member]
Warrants to the private placement		$ 3,548,426

Schedule of Restricted Shares and Restricted Share Units Non-vested (Details) - $ / shares	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Units, Unvested share awards, Beginning	3,176,967	3,428,604	3,428,604
Units, Granted	5,822,024	185,742
Units, Vested	(924,430)	(410,504)
Units, Forfeitures	(21,770)	(26,875)
Weighted average grant date fair value, Unvested share awards, Beginning		$ 4.90	$ 4.90
Weighted average grant date fair value, Granted			0.96
Weighted average grant date fair value, Vested			2.43
Weighted average grant date fair value, Forfeitures			$ 6.76
Units, Unvested share awards, Ending	8,052,791	3,176,967	8,052,791
Weighted average grant date fair value, Unvested share awards, Ending	$ 2.33		$ 2.33

Schedule of Stock-Based Compensation Expense (Details) - USD ($)	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	$ 9,502,030	$ 7,691,511
Cost of Sales [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	267,449
General and Administrative Expense [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	6,836,740	4,083,070
Research and Development Expense [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	2,295,427	2,659,061
Exploration [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	$ 102,417	$ 949,380

Equity Compensation Awards (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Award vest rate			25.00%
Outstanding percentage						10.00%
Number of restricted shares issued, shares	5,822,024	185,742
Vested value	$ 1,000,000.0
Sharebased compensation expense			$ 9,502,030	$ 7,691,511
Unamortized expenses related to compensation	$ 20,600,000		$ 20,600,000
Weighted-average period			3 years 2 months 12 days
Officer [Member] \| Warrant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Equity compensation					$ 400,000
2021 Equity Retention Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of restricted shares issued, shares	5,800,000

Schedule of Statement of Cash Flow Disclosures (Details) - USD ($)	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Supplemental disclosures:
Interest paid	$ 4,575	$ 14,462
Non-cash investing and financing activities:
Purchases of property and equipment accrued in current liabilities	225,104
Deposits capitalized as investing activities		27,103,351
Right-of-use asset obtained in exchange for lease liability	367,643
Debt payment satisfied with common shares	1,742,580
Payable recognized upon rescission of subscription agreement	$ 875,000

Commitments and Contingencies (Details Narrative) $ in Millions	Dec. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Financial assurance reclamation or restoration cost	$ 0.1

American Battery Technol... (NASDAQ:ABAT)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025

Plus de graphiques de la Bourse American Battery Technol...

American Battery Technol... (NASDAQ:ABAT)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ABAT American Battery Technology Company

Actualités American Battery Technology Company

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

ABAT American Battery Technology Company

Actualités American Battery Technology Company

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités